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Background: A diabetic foot ulcer (DFU) is a feared complication of diabetes. Both 
duration and severity of ulcer before start of treatment in specialist health care are 
factors that can effect healing time for patient with DFUs. More research about duration 
and severity of DFUs before seeking care as predictors of healing time might contribute 
to knowledge of importance for clinical interventions. Treatment of DFUs puts 
pressure on the health care system in terms of utilization of available resources. 
Moreover, the prevalence of diabetes is increasing dramatically and, as a result, long-
term diabetes-related complications are also likely to increase. Telemedicine can be 
one way to address these issues, because telemedicine follow up may enable more 
integrated care pathways across health care levels. Telemedicine has been used in 
different settings, but knowledge of telemedicine’s effect on clinical outcomes and 
patients’ experiences among patients with DFUs is limited. 
 
Aims: The overall aim of this study was to provide new knowledge about predictors of 
healing time in patients with a DFU and to assess the effect of and experience with a 
telemedicine intervention for patients with a DFU. To achieve the overall aim, three 
specific aims were established:  
1) to investigate whether A) duration of ulcer before start of treatment in specialist 
health care, and B) severity of ulcer according to the University of Texas (UT) 
classification system at the start of treatment (baseline), are independent predictors 
of healing time; 
2) to evaluate whether telemedicine follow up of patients with DFUs treated in 
primary health care, in collaboration with hospital outpatient specialist care, is non-
inferior to standard outpatient care in terms of ulcer healing time. Further, to assess 
for superior whether amputations, death, consultations and patient satisfaction are 
different from telemedicine follow up compared to standard outpatient care; and, 
3) to explore the experiences of patients with DFUs receiving telemedicine 
compared to patients receiving standard outpatient care health care delivered in the 
context of a cluster randomised controlled trial. 
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Methods: Three different study designs were used. Study I: A retrospective cohort 
study included data from electronic medical records system of 105 patients with new 
DFUs from two outpatient clinics in Western Norway during 2009-2011. Competing 
risk regression with adjustment for potential confounders was used to evaluate the 
associations of duration and severity of the ulcer with healing time. Study II: In this 
pragmatic cluster randomised controlled non-inferiority trial, 182 patients (94/88 in 
telemedicine/standard outpatient care; 42 clusters) with a new DFU were recruited 
from three hospital outpatient clinics in Western Norway (from September 2012 to 
June 2016). The primary endpoint was healing time and secondary endpoints included 
amputation, death, number of consultations per month, and patient satisfaction. Study 
III: In the qualitative study individual interviews were conducted with 24 adults 
recruited from the cluster randomised controlled non-inferiority trial (n=13/ n=11 from 
the telemedicine /standard outpatient care group) in the period March 2014-May 2015. 
 
Results: Study 1: Of the 105 adults, 48 (45.7%) achieved ulcer healing, 38 (36.2%) 
underwent amputations, 10 (9.5%) died before ulcer healing and 9 (8.5%) were lost to 
follow up. For those who healed, mean healing time was 3.8 months (113 days), 
measured from start of treatment in the specialist health care to end of follow up. Time 
from patient-reported ulcer onset to referral by general practitioner (GP) to specialist 
health care was found to be a strong predictor of healing time. Patients who were 
referred to specialist health care by a GP ≥ 52 days after ulcer onset had a 58% (Sub 
hazard ratio (SHR) 0.42, CI 0.18, 0.98) decreased healing rate compared with patients 
who were referred earlier. Ulcers with the highest severity i.e. ulcer penetrating to 
tendon or bone (grade 2/3) and peripheral arterial disease with and without infection 
(stage C/D) according to the UT classification system had an 86% (SHR 0.14, CI 0.05, 
0.43) decreased healing rate compared with low severity i.e. superficial ulcer (grade 1) 
with infection (stage A/B) or ulcer penetration to tendon/capsula (grad 2) and clean 
ulcer (stage A). Study II: Of 182 patients, 142 (78.9%) achieved complete ulcer 
healing, and 75 (79.8%) healed in the telemedicine group and 67 (76.1%) in the 
standards outpatient care group. Mean healing including only those who healed was 
3.4 months and 3.8 months in the telemedicine group and standard outpatient group, 
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respectively. Telemedicine was non-inferior to standard outpatient care regarding 
healing time (mixed-effects regression analysis: (mean difference –0.43 months, 95% 
CI –1.50, 0.65). This finding persisted also after taking into account competing risk 
from death and amputation (SHR 1.16, 95% CI 0.85, 1.59). There were no significant 
differences between the telemedicine follow up and standard outpatient care related to 
the effect estimate of the secondary outcomes, except for significantly fewer 
amputations in the telemedicine group. Study III: Three themes emerged from the 
analysis: 1) competence of health care professionals, 2) continuity of care, and 3) easy 
access, i.e. to receive treatment and follow up near home or at their home. Group 
allocation seemed to have limited impact on the patients’ follow-up experiences. 
Competence of health care professionals and continuity of care were important, 
because they could either enhance or impair wound care. When telemedicine 
functioned as intended, it was an advantage in the treatment. Easy access was important 
for the participants, but the importance of accessibility appeared only when 
competence among health care professionals and continuity of care were present.  
 
Conclusions: Early referral to specialist health care if an ulcer occurs is crucial for 
optimal ulcer healing and has a clear implication for routine care. Grade and  stage 
severity are also important predictors for healing time, and early screening to assess 
the severity and initiation of prompt treatment is important. Telemedicine can be an 
alternative but also a supplement to usual care for patients with DFUs, at least for 
patients with more superficial ulcers. As the number of outpatient clinic consultations 
in the telemedicine group did not differ from the standard care group, there is need to 
focus on organisational aspects to facilitate the use of telemedicine. Health care 
professionals’ competence, continuity of care and easy access to health care services 
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BEON Best Effective Care Level  
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 INTRODUCTION  
A diabetic foot ulcer (DFU) is a severe and disabling complication of diabetes and is 
usually caused by a combination of neuropathy and peripheral vascular disease (1) . 
These ulcers will often need intensive treatment, frequent ambulatory care visits and 
hospitalisation (2). The ulcers can take months to heal and about 20% of infected ulcers 
will require some form of amputation (3). Approximatly 40% of patients will have a 
recurrence within one year after ulcer healing (4). A history of foot ulcer is also 
significantly associated with increased mortality (5, 6) and reduced quality of life (7). 
The effect of factors promoting ulcer healing such as offloading, infection therapy, 
vacuum-assisted closure therapy and hyperbaric oxygen therapy are well documented 
(8). Less attention has been given to whether a delayed referral to specialist health care 
could be a factor associated with healing time, despite delayed referral being 
considered as a risk factor for lower extremity complications (9, 10). Use of screening 
tools to identify patients at risk of developing foot ulcers at an early stage is also 
important. The University of Texas (UT) classification system for diabetic foot ulcers 
is one of the few systems that has been validated in different countries (11-13), 
highlighting the need for more research to assess to what degree this system reflects 
different populations and predicts healing time accordingly (14) . 
Treatment of DFUs is complex and costly and puts pressure on the health care system 
(4, 15-19). It is likely that the number of patients with DFUs will continue to increase 
due to an increasing incidence of diabetes, especially type 2 diabetes (18, 20). As a 
consequence, comorbidities of diabetes such as foot ulceration, peripheral vascular 
disease, osteomyelitis and lower extremity amputation are also expected to increase 
(18, 20-22). This will result in high demand for alternative care pathways for treatment 
of DFU (20).  
Telemedicine follow up may be an effective approach to wound care management to 
meet these challenges. Telemedicine has the potential to enable more patients to be 
treated in or near their homes and to reduce the number of consultations in specialist 
2 
health care by transferring a larger proportion of treatment and follow up to primary 
health care while maintaining high-quality wound care (23-25). However, we lack 
knowledge about the effect of telemedicine follow up on clinical outcomes such as 
healing time, amputation and death as well as patients’ experience with receiving 
telemedicine follow up (25-27). 
Thus, the overall aim of this study was to provide new knowledge about predictors of 
healing time in patients with a DFU and to assess the effect of and experience with a 
telemedicine intervention for patients with a DFU. 
1.1 Diabetes and diabetic foot ulcer 
Diabetes mellitus is expected to increase dramatically both in Norway and globally (18, 
20, 28). Globally, the prevalence of diabetes has been estimated to be 415 million, and 
it is projected to reach 642 million by 2040 due to an ageing population, physical 
inactivity and obesity (28). Diabetes is characterised by an increased risk of 
macrovascular (stroke, coronary artery disease and peripheral arterial disease) as well 
as microvascular (neuropathy, nephropathy and retinopathy) complications (29).  
Foot ulceration is among the most severe complications of diabetes (30). The 
International Working Group on the Diabetic Foot has defined a diabetic foot ulcer in 
the following way: “full thickness skin breakdown below the ankle in a person with 
diabetes, irrespective of duration” (31), and this definition has been used in the studies 
in this dissertation. 
Diabetic foot lesions rarely occur spontaneously, but rather in interaction with two or 
more risk factors, where diabetic peripheral neuropathy and peripheral arterial disease 
play central roles (1). Diabetic peripheral neuropathy and peripheral arterial disease 
may act in combination with other factors such as foot deformity, previous diabetic 
foot ulceration or lower extremity amputation (1, 11, 32). All these potential risk 
factors are consistently associated with increased risk of ulceration. Risk factors that 
have inconsistently been associated with risk of ulceration are older age, male gender, 
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diabetes of longer duration and high HbA1c (11). A systematic review reported that in 
patients with no previous history of foot ulceration or amputation, the predictive factors 
for increased risk of foot ulceration were inability to feel a 10-g monofilament test, 
absence of at least one pedal pulse and longer duration of a diabetic diagnosis (33). 
DFUs are usually classified into two groups: neuropathic ulcers and ischemic ulcers 
(1). The majority of foot ulcers are neuro-ischaemic, caused by a combination of 
neuropathy and peripheral arterial disease. Neuropathy often leads to loss of sensation, 
foot deformities and abnormal walking patterns that can cause abnormal biomechanical 
loading on the foot (30). This results in high pressure in some areas leading to callus 
(thickened skin) often causing subcutaneous haemorrhage and ulceration. A minor 
trauma can result in ulceration of the foot (30). Peripheral arterial disease is generally 
caused by arteriosclerosis and is present in up to 50% of patients with DFUs (34-38). 
Peripheral arterial disease is an important risk factor for reduced ulcer healing, 
increased risk of infection and lower extremity amputation (30, 35, 39, 40).  
Incidence of diabetic foot ulcer 
The incidence rate of diabetic foot ulceration reported in some large population-based 
studies varies (41-45). In Norway, two previous studies from the population-based 
HUNT study (1995-1997; 2006-2008) showed a possible decrease in the cumulative 
incidence of people reporting a history of DFU (46, 47). The cumulative incidence of 
foot ulcers reported in HUNT3 (7.4% (95% CI 6.2%, 8.6%) appears to be lower than 
in HUNT2 (10.4% (95% CI 8.8%, 11.9%). In a recent study from Denmark, among 
5,640 patients with diabetes type I, the incidence of DFUs decreased from 8.1 in 2002 
to 2.6 per 1000 patient years in 2014 (48). Among 6,953 patients with diabetes type II 
in the same study, the incidence of DFUs decreased from 17.0 to 8.7 per 1000 patients 
years in the same period. In a study of 81,793 Dutch people with diabetes during 2010-
2013, the annual incidence rate estimated was 0.34% (range 0.22 – 1.08%) for all DFUs 
(42). This is lower than reported from some previous studies (43-45, 49). A 
community-based study from North-West England reported a 2.2% annual incidence 
rate of diabetic foot ulceration during a 2-year follow up in the period 1994-1996 
among 6,613 patients with diabetes (43). In a study from USA collecting retrospective 
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data from 8,905 people with diabetes in the period 1993-1995, Ramsey et al. (44) 
reported a cumulative 3-year incidence of 5.8%. More recently from Ireland, Hurley et 
al. in 2008-2009 reported an annual incidence rate of 2.6% from general practice 
among 563 patients with diabetes (45).  
Healing of diabetic foot ulcer 
Results from the Eurodiale study showed that 77% of DFUs healed (with or without a 
minor amputation) within 1 year (32). The prevalence of peripheral arterial disease was 
approximately 48% and was associated with poorer ulcer healing. Uccioli et al. (35) 
included patients with critical limb ischaemia and found the healing rate among 
patients treated with percutaneous angioplasty to be 62.3%, and without to be 48.1%.  
The majority of healed ulcers healed in less than 6 months. Ulcers with an ulcer area > 
5cm2, infection, a combination of infection/ischemia and the presence of ischemic heart 
disease had significantly reduced healing. A United Kingdom cohort study included 
449 patients with ulcers that were at different stages and grades based on the UT 
classification system (50). In total, 65.7% of the ulcers healed within 6 months, but 
only 59.2% remained healed after 12 months. Median healing time was 78 (range 7-
364) days. Oyibo et al. (13) included patients with neuropathy and neuroischaemic 
ulcers. Of these, 67.0% were neuropathic and 26.3% were neuroischaemic. Of the 194 
patients, 65% achieved ulcer healing. The median healing time for those who healed 
was 5 weeks. A higher stage in the UT classification system was associated with 
increased healing time. In summary, results from these studies showed that about 25-
40% of ulcers do not heal (13, 32, 35, 50). The most important predictors for non-
healing ulcers in the Eurodiale study were peripheral arterial disease either alone or in 
combination with infection (32). 
Amputations  
There is global variation in the incidence of amputation (10, 51, 52). In 1989, the aim 
of the St. Vincent Declaration was to reduce the rate of amputation among people with 
diabetes by half within 5 years (53). This 5-year goal was almost achieved after 20 
years, as indicated by the reduction in incidence of lower extremity amputation 
reported in several studies (52, 54-56).  
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A report from the Organization for Economic Cooperation and Development (OECD) 
found a 40% decline in amputations among patients with diabetes over a 12-year 
period, with rates ranging from a mean of 13.2 to 7.8 amputations (minor and major) 
per 100,000 from 2000 to 2011 respectively (55). However, despite a reduction in 
amputation rate across these 12 years, it still remains high in most OECD countries 
(55). 
The incidence rates of amputations are reported from some countries. In Norway, the 
incidence of amputations among patients with diabetes decreased from 2.4 amputations 
per 1000 in 2015 to 2.3 amputations per 1000 in 2016 (56). In the Eurodiale study, 
minor amputations among patients with diabetes differed markedly between countries 
ranging from 2.4% to 34%, suggesting that different management strategies and 
referral patterns between and within these countries might explain these variations (57). 
In a study in the Netherlands, the incidence rate of amputations as a consequence of 
diabetes was relatively low and stable over the years 2007-2011 (58). The annual rate 
of amputations between 2009 and 2011 ranged from 4.32 to 5.28 per 1000 patients in 
the secondary care sector. Kennon et al. (54) found a significant reduction in the 
incidence of amputations caused by diabetes in Scotland over a 5-year period. The 
incidence was reduced from 3.04 per 1000 in 2004 to 2.13 per 1000 in 2008 (p > 0.001), 
mainly due to a reduction in major amputations. 
The incidence of amputation can be difficult to compare due to variation in the 
definition of amputation and the population selected (10, 51). Different factors can 
influence the decision as to whether or not to perform an amputation. A high incidence 
of amputations can indicate high disease prevalence, limited resources, late referral or 
a surgical intervention approach (10). In contrast, a low incidence of amputations can 
reflect a lower disease prevalence, a conservative approach or good foot care in primary 
and specialist health care. A high incidence of minor amputations could be regarded as 
a strategy leading to healing whereas major amputation cannot be regarded in this way. 
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Mortality 
There is strong evidence for excess mortality associated with DFU. A 10-year follow-
up community-based study in Norway reported a mortality rate of 49% among 155 
patients with a history of DFU compared with 35.2% among 1,339 patients with 
diabetes without DFUs and 10% of the 63,632 individuals without diabetes (5). In 
another study, an 11-year retrospective hospital study from the UK, including 268 
patients with DFUs. Patients with a DFU had an increased mortality risk compared 
with non-ulcerated patients with diabetes. Ischaemic heart disease was the major cause 
of premature death and higher among patients who had neuropathic ulcerations 
compared to non-ulcerated patients with diabetes (6). Similar results were seen in 
Norway, but the proportion of patients who died due to cardiovascular disease did not 
differ between patients with diabetes with and without a DFU: 48.7% versus 50.1%, 
respectively (5). 
1.2 Predictors of diabetic foot ulcer healing 
Despite clinical guidelines recommending early referral of patients with DFUs (59-62), 
relatively few studies have investigated duration of ulcer as a predictor of ulcer healing 
(9, 63, 64).  
An ulcer classification system to detect DFUs at an early stage to predict outcomes is 
of clinical importance, but no classification system is currently in widespread use (65), 
neither in Norway nor globally. The Norwegian diabetes national professional 
guideline from 2016 recommend using the Scottish Intercollegiate Guidelines Network 
(SIGN) classification system (59). How this should be used in clinical practice is not 
specified, but the SIGN system is soon to be incorporated into the Norwegian Diabetes 
Register for Adults (NOKLUS). 
1.2.1 Duration of ulcer before treatment start in specialist health care 
Norwegian and international guidelines recommend early referral of patients with 
DFUs to specialist health care to avoid severe complications (59-62). Although some 
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researchers have reported a relationship between duration of ulcer and ulcer healing 
among patients with DFUs (63, 66), many patients with DFUs still experience delayed 
referral to specialist health care (9, 63), possible due to lack of awareness of potential 
consequences of the delay, lack of knowledge among health care professionals and 
patients, as well as poor management strategies (9, 67, 68).  
A sub-study within the Eurodiale study found that late referral defined as 3 months or 
longer before treatment started in specialist health care was found in 27% of all 
patients, ranging from 6% in the UK to 55% in Germany. Nearly half of these patients 
(44%) had been treated in primary health care experienced a late referral (9). The 
Eurodiale study data also showed marked differences in minor amputation rates 
between the different European countries. The authors suggested that one reason 
behind these variations might be the referral patterns in the various countries (57). 
However, referral patterns were not investigated in the Eurodiale study. 
Only a few studies have found an association between duration of ulcer before 
treatment start in specialist health care and healing time. In a recent British audit 
including 5,105 patients from 129 specialist foot care teams (63), patients with DFUs 
who were referred to specialist health care more than 2 months after ulcer onset had 
significantly increased healing time compared with those who were referred earlier. 
Margolis and colleagues (66) found after evaluating more than 31,000 individuals with 
diabetic neuropathic forefoot ulcers that the ulcers were more likely to heal if the 
duration of the ulcer had been less than 6 months before treatment start in specialist 
health care. It was therefore of interest to examine the association between this factor 
and healing time among patients with DFUs in a Norwegian cohort study. 
1.2.2 Severity of ulcer before treatment start in specialist health care 
The severity of ulcers at presentation in specialist health care may affect the outcome. 
Studies have shown that the presence of infection and/or ischaemia increases the risk 
of amputation (13, 57), and that early detection of peripheral arterial disease, treatment 
of infection and surgical intervention can improve the outcome for the patients (35). 
Peripheral arterial disease is strongly linked to poor ulcer healing and it is present in 
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up to 50% of patients with DFU (36, 69, 70). Early screening of people with a DFU is 
important to assess the severity of the ulcer and to initiate adequate treatment to reduce 
the risk of severe complications. The UT classification system was validated in 1998 
in the USA (12) and in 2001 in the UK (13) and demonstrated prediction of amputation 
and healing time (12, 13). However, it is emphasised that more research is needed to 
assess to what degree this system reflects the population for which it is intended (14).  
1.3 Telemedicine as a health services delivery tool 
There is considerable interest in the capacity of information and communication 
technologies (ICTs) to improve the outcomes of the health care service and ICTs may 
have the potential to meet with some of the challenges the health care service faces by 
enhancing access to, as well as efficiency, quality and cost-effectiveness of the health 
care services (23, 71-73). Telemedicine is presented as one solution that can deliver 
health care at a distance, especially for those with complex conditions, allowing more 
patients to be treated according to the BEON (Best Effective Care Level) principle (24). 
Telemedicine may provide continuous patient care pathways across health care levels 
and reduce the number of outpatient consultations (23, 24, 73-75). Use of telemedicine 
leads to new ways of organising health care services. However, the adoption of this 
technology is challenging (72, 73, 76, 77). 
Different definitions have been used for the concept of telemedicine (78-81). 
‘Telemedicine’ and ‘telehealth’ are the most frequently used terms (82). The World 
Health Organization has defined telemedicine broadly as follow: 
“The delivery of healthcare services, where distance is a critical factor, by all 
healthcare professionals using information and communications technologies for the 
exchange of valid information for diagnosis, treatment and prevention of disease and 
injuries, research and evaluation, and for continuing education of healthcare 
providers, all in the interest of advancing the health of individuals and their 
communities” (23). 
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Telemedicine encompasses different technologies and is often classified into two types: 
store-and-forward teleconsultation (asynchronous, low-tech solution) and 
videoconferencing (synchronous, high-tech solution) (83, 84). The asynchronous 
application includes communication between patient and health care professional via 
email, cell phone, automated messaging or other equipment without face-to-face 
contact. The patients and the health care professionals do not need to be present at the 
same time. Synchronous solutions involve a lot of organisation and require face-to-face 
contact via videoconferencing, equipment and timing of involved stakeholders. In DFU 
care, asynchronous solutions are often used to provide close integrated care of patients 
between health care levels (85). 
1.3.1 Telemedicine follow-up care of patients with DFUs   
The Norwegian Coordination Reform (2008-2009) highlights the lack of a holistic 
approach to patients’ needs in the current organisation of the health care system and 
emphasises the requirement for more coordinated and integrated health care for 
patients, especially for patients with complex conditions (24). The growing pressure 
on the health care system to deliver care to patients requires new approaches to 
organising the health care system. The use of ICT has been highlighted as an important 
aid in achieving a more coordinated and integrated health service (24), a process that 
emphasises seamless collaboration and continuity of care tailored to the needs of the 
patient (86).  
In the current health care system in Norway, the general practitioner (GP) serves as a 
‘gatekeeper’ by coordinating medical follow up to specialist health care (87). If a 
person needs an assessment from specialist health care, the GP is responsible for 
sending the referral to the actual specialist (88). The majority of specialist assessments 
and treatments are initiated with a referral from a GP. In Norway, the right to necessary 
health care from the specialist health care service is regulated by law (89). Priority 
depends on severity, the need for specialist health care, the likely benefit, the 
availability and the cost-effectiveness (90). The decisions are based mainly on the 
information from the GP’s referral letter (89). However, some confusion exists as to 
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whether the patient with a DFU should be referred to the orthopaedic, surgical, 
dermatology or endocrinology department. In the Norwegian context, this often leads 
to different follow-up procedures for patients with DFUs (91). There are indications 
that patients with DFUs are treated for a substantial length of time in primary health 
care with limited continuity of care, few specialist nurses and lack of integrated care 
between health care levels (92, 93). A delayed referral to specialist health care is 
reported in some studies (9, 63, 66), despite international and national guidelines 
stressing the importance of early referral to specialist health care when ulcers occur to 
prevent severe complications (59, 61, 62). 
Telemedicine interventions may enable a more coordinated and integrated health care 
between health care levels (83, 84). Telemedicine allows a direct communication 
between health care levels and between patients and health care professionals. Follow-
up care of foot ulcers requires careful monitoring of treatment and follow up. By using 
interactive platforms combined with photographic devices and electronic transfer of 
high-quality digital images, remote assessment of wound status is possible while still 
maintaining high-quality care (75). This may reduce patient transportation and 
workload in specialist health care by decreasing the number of consultations in 
specialist health care. Telemedicine seems especially useful in wound management 
where a strong visual component is present in the assessment and follow up of ulcers 
(25, 75). In the systematic review published by Singh et al. (25), the authors concluded 
that telemedicine technology provides high diagnostic accuracy in diabetic foot 
management, and patients as well as health care professionals are positive about its use. 
However, it is not clear if telemedicine use in patients with DFUs has favourable 
clinical outcomes, and therefore more randomised controlled trials are needed (25) . 
1.3.2 Telemedicine follow up compared to standard care related to 
clinical outcomes of DFUs 
The literature in the context of telemedicine follow up of wound care includes to a large 
extent feasibility studies and small-scale studies (25, 94). One systematic review from 
Norway evaluated clinical, behavioural and organisational effects of telemedicine 
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regarding leg ulcers and diabetic foot ulcers (27). The authors concluded that there was 
insufficient evidence to determine whether telemedicine was as effective as standard 
outpatient care. Some studies have focused on telemedicine follow up compared with 
standard outpatient care on the effect on foot ulcer healing (95-99). Less focus has been 
on outcomes such as amputation and death, as well as patients’ experiences (95).  
Ulcer healing and healing time 
A randomised controlled trial (RCT) involving 374 home care patients with DFUs in 
Denmark in 2015 found no significant differences in incidence of healing between 
telemedicine follow up compared with standard outpatient care (95). No difference was 
reported in complete healing between the two groups. Similar results were found in a 
non-randomised study from USA which included 140 consecutive patients with DFUs 
from two medical centres (96). There were no statistically significant differences in 
healing time between patients receiving telemedicine and traditional follow up after 12 
weeks. Moreover, no statistically significant differences between groups were observed 
in the number of ulcers that had healed at 12 weeks. The authors suggested caution 
with respect to the results due to the low sample size and the risk of type 2 error, but 
emphasised that telemedicine was a feasible method for delivery of foot care to rural 
populations; however, more trials were needed. In an American  study, Terry et al. (97) 
reported results of a prospective RCT on 103 home care adults with pressure ulcers or 
non-healing surgical wounds, claiming no benefit from the use of telemedicine in 
wound care. They found no statistically significant differences between the groups, and 
the results did not favour the telemedicine intervention. In contrast, Zarchi et al. (98) 
reported results of a non-randomised cluster-controlled trial with 95 home care patients 
with ulcers of mixed etiology (DFUs were included). This Danish study reported 
benefit from using telemedicine in wound healing. Telemedicine follow up was 
associated with significantly increased healing compared with standard outpatient care 
after adjusting for covariates. More patients healed in the telemedicine group compared 
with the control group. In the telemedicine group, 70% healed (35 of 50) compared 
with 45% (18 of 40) in the control group. A study from Australia concluded that 
telemedicine can support both patients and clinicians (99). A total of 93 patients 
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(telemedicine group n=50, control group n=43) were included in a 12-month 
prospective randomised cluster-controlled study including patients with ulcers of 
mixed etiology (DFUs were not included). Patients receiving telemedicine follow up 
had a positive healing rate of 6.8% per week, while the control group had a negative 
healing rate per week of -4.9% per week (p=0.012). 
Amputations 
In the previous mentioned Danish study by Rasmussen et al. (95), the authors found no 
significant differences in the incidence of amputations or in healing time between the 
groups and suggested that telemedicine was a relevant alternative to standard outpatient 
care. In the Australian study, Santamaria et al. (99) reported that 1 (2%) patient in the 
telemedicine group had amputation compared with the 6 (14.0%) in the control group. 
Mortality 
The results from the Danish study by Rasmussen et al (95) reported higher mortality in 
the telemedicine group compared with standard outpatient care. The authors presented 
no reasons that could explain these results. Despite the promising results of no 
difference in healing and amputation rate between the groups, the authors concluded 
that a more cautious approach to telemedicine follow up in patients with DFUs should 
be considered. Furthermore, more RCTs are recommended involving different 
subgroups to identify patients who can benefit most from a telemedicine intervention. 
Findings from the Australian study showed that 2 (4.7%) died in controlled group 
compared with none in the telemedicine group  (99).  
Overall, evidence on telemedicine follow up in wound care is limited and characterised 
mostly by low powered studies, heterogeneity in populations, methods and 
interventions applied, making study results difficult to compare (95-99). Only one RCT 
and one non-randomised controlled study focused specifically on DFUs and use of 
telemedicine follow up (95, 96). Few studies have reported on clinical outcomes such 
as ulcer healing, amputation and mortality. The results from these studies related to 
healing time are inconclusive as to whether telemedicine follow-up care is superior or 
no worse when compared with standard outpatient care. In conclusion, more evidence 
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is needed regarding the effect of telemedicine follow up compared standard outpatient 
care on clinical outcomes among patients with DFUs. No such study had, before ours, 
been performed in Norway. 
1.3.3 Telemedicine follow up from a patient perspective  
There are some reviews focusing on telemedicine and patient satisfaction, but not 
specifically for patients with DFUs. Overall, these reviews reported that the majority 
of patients found telemedicine satisfactory, but they also report methodological 
deficiencies and the need for further studies (100-102). However, some small studies 
about telemedicine and patient satisfaction in wound care have been published (103-
107), but those related to telemedicine in diabetic foot care from the perspective of 
patients is limited (108, 109). Below is a summary of the studies that have explored the 
experiences with telemedicine follow up among patients with DFUs. 
In a Danish pilot study, Clemensen et al. (109) conducted a qualitative study involving 
patients with DFUs, expert nurses, visiting nurses and a doctor in Denmark. The 
telemedicine intervention consisted of three video consultations that substituted three 
consultations at the outpatient clinic. All stakeholders reported satisfaction with the use 
of telemedicine. Patients emphasised the benefits of staying home during treatment, 
avoiding long transportation time and waiting time at the outpatient clinic, as well as 
increased contact between the patient and health care professionals. The authors 
concluded that telemedicine was useful and an appropriate alternative to standard 
outpatient care in these cases. Another study evaluated the experiences of five patients 
with DFUs who received telemedicine follow up by the community health podiatrist in 
an Australian rural community (108). The podiatrist sent image and text via mobile 
phone to the specialist clinic. The patients reported satisfaction with the use of 
telemedicine follow up with respect to immediacy of service, benefit of time saving, 
reduced travel time and cost saving. The author concluded that telemedicine follow up 
could be a useful supplement to standard outpatient care. 
In summary, few studies have evaluated experience with telemedicine follow up among 
patients with a DFU, and evidence from RCTs that include the patients’ perspective is 
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scarce. There is a need to incorporate qualitative approaches that might provide a more 
in-depth insight into the experiences of patients when new technology is used and 
provide additional insight into whether the setup is working as intended. Therefore, 
there is a need for more knowledge on the patient perspective on telemedicine 
intervention among patients with a DFU in large controlled trials. 
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 OBJECTIVES 
The overall aim of this study was to provide new knowledge about predictors of healing 
time in patients with a DFU and to assess the effect of and experience with a 
telemedicine intervention for patients with a DFU. 
The specific aims of the thesis were as follows: 
Study I:  
To investigate the association between duration of ulcer and healing time. Duration of 
ulcer was defined as the time from patient-reported ulcer onset to start of treatment in 
specialist health care and was divided into two different fractions of duration of ulcer 
(Figure 2, p.20): 
1) time from patient-reported ulcer onset to referral by GP to specialist health care, 
and 
2) time from referral by GP to start of treatment in specialist health care  
In addition, we explored whether severity of the ulcer in terms of grade and stage (as 
defined in the UT classification system) at start of treatment in specialist health care 
was associated with healing time. We also investigated whether duration of ulcer and 
ulcer severity showed independent associations after mutual adjustment and 
adjustment for other potential confounders (Table 2, p.21). 
Study II:  
The primary aim was to evaluate whether telemedicine follow up of patients with 
diabetes-related foot ulcers in primary health care, in collaboration with hospital 
outpatient specialist care, is non-inferior to standard outpatient care in terms of ulcer 
healing time. Our secondary aims were assessed for superiority: to evaluate whether 
amputations, death and outpatient consultations were less frequent in the telemedicine 
group compared to standard outpatient care; and to evaluate whether patients receiving 
telemedicine follow-up care were more satisfied with the treatment and follow-up care 
than patients receiving standard outpatient care. 
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Study III:  
To explore the experiences of patients with diabetic foot ulcers receiving telemedicine 
compared to patients receiving standard outpatient health care delivered in the context 
of a cluster randomised controlled trial. 
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 MATERIAL AND METHODS 
Three different research designs were used in this dissertation: a retrospective cohort 
study (Study I), a pragmatic cluster RCT (non-inferiority) (Study II) and interpretive 
description (qualitative strategy) (Study III). Study III was designed in the context of 
the cluster non-inferiority RCT. 
Table 1. Study overview 
Study Methods/Design Sample Data collection Analysis 
I Retrospective cohort 
study 
n=105 patients with 
diabetic foot ulcers 
 






Descriptive statistics (mean, 
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II Cluster randomised 
controlled non-
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n=182 patients with 
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3.1 Study I 
3.1.1 Design 
A retrospective cohort design was used to assess the associations between duration of 
ulcer, severity of ulcer with healing time. 
3.1.2 Study sample 
Patients with DFUs registered at two outpatient clinics in Western Norway: the 
Endocrinology units at Stavanger University Hospital and the surgical unit at Stord 
County Hospital between January 2009 and December 2011 were included.  
The inclusion criterion was: Patients with a new DFU presenting for the first time at 
one of the participating clinics. Exclusion criterion was: Patients treated for a foot ulcer 
on the same foot in the past 12 months before treatment start in specialist health care. 
To identify patients with DFUs, different approaches were used: At Stavanger 
University Hospital, the appointment system in the electronic medical records and the 
appointment book for consultations were used to identify patients with a DFU. At Stord 
Hospital, the following ICD codes were used: L97: Unspecified wound of lower limb, 
L89.9: Unspecified bedsore or decubitus ulcer, , E10.5: Type 1 Diabetes mellitus with 
peripheral circulatory complications, E10.6 Diabetes 1 with special complications, 
E10.7: Diabetes 1 with multiple complications, E11.5: Type 2 Diabetes mellitus with 
peripheral circulatory complications, E11.6: Diabetes 2 with special complications, E 
11.7: Diabetes 2 with multiple complications and M86.6: Osteomyelitis. In additional, 
the following NCMP/NCSP procedure codes were used: Qxb99: Unspecified dressing, 
Qdb05: Debridement on lower extremity, Qdb10: Larger dressing procedure on lower 




3.1.3 Data collection  
Data were collected from medical electronic record system at baseline and 
prospectively on ulcer healing, amputation and death using a standardised data 
collection form (Appendix 1). The data collection form was piloted on five patients 
(three patients at Stavanger University Hospital, two at Stord Hospital) to see if it was 
feasible to collate information on the variables via the data collection form. Not all 
variables included in the data collection form were used in this study. Data on weight, 
height and body mass index could not be collected from the electronic medical records 
system and the questions were removed from the data collection form. A specialist 
nurse at each outpatient clinic collected data from the medical electronic record system 
These data were filled into the data collection form by the first author (HSS). 
A total of 151 patients were assessed for eligibility, and 105 were included. Written 
informed consent from participants was obtained (REK 2013/2327). Figure 1 gives an 





Figure 1. Flowchart. Study population 
SHC=specialist health care 
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3.1.4 Main exposures and possible confounders 
The main exposures in this study were duration of ulcer and ulcer severity. Duration 
of ulcer was defined as the time from patient-reported ulcer onset to start of treatment 
in specialist health care (P total) and divided into two fractions (Figure 2). 
P1: Time from patient-reported ulcer onset to referral by GP to specialist health care 
divided into 3 groups using the following tertiles: 0-13 days, 14-51 days and ≥52 
days and, 
P2: Time from referral by GP to start of treatment in specialist health care divided 




Ulcer severity was classified according to the UT classification system (12, 13). This 
system assesses ulcer depth, the presence of wound infection and clinical signs of lower 
extremity ischaemia (12, 110).The system uses a matrix of grades on the horizontal 
axis and stages on the vertical axis, consisting of four grades and four stages, shown in 
Table 2. The matrix in Table 2 is shaded to differentiate between ulcer severities. A 
higher grade /stage indicates a more severe ulcer. Based on clinical judgement, grade 
Figure 2.  Model illustrating the relation between duration of ulcer and healing time 
P1= Patient reported ulcer onset to referral by general practitioner (GP) to specialist health care (SHC) 
P2= referral from GP to start of treatment in SHC 
P total = P1 and P2 
Healing time = from start of treatment at SHC to healing or end of follow- up 
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and stage were combined into three categories before analysis due to small numbers in 
some categories (Table 2).  
Table 2. Matrix of University of Texas classification system 
Stage   
 
Grade 0 Grade 1 Grade 2 Grade 3 
A Clean wound     
B PAD -, infection +     
C PAD +, infection -     
D PAD +, infection +     
PAD: Peripheral arterial disease 
Grade 0: Pre-or post-ulcerative lesion, Grade 1: Superficial wound, not involving tendon, capsule or bone,                          
Grade 2: Wound penetrating to tendon or capsule, Grade 3: Wound penetrating to bone or joint 
Low severity: light grey shadow, medium severity: grey shadow and high severity: dark grey shadow 
 
If the patient had more than one ulcer, the most severe ulcer was selected as the index 
ulcer based on the UT classification system by clinical judgement of health care 
professionals in the clinic. This selection was made before data were collected. 
Potensial confounders 
Potential confounders were selected based on the literature and expert advice from 
clinicians and epidemiologists. These were sex, age, HbA1c, coronary disease, vascular 
surgical treatment and neuropathy. Justification for the choices of the confounders are 
described at page 44. 
3.1.5 Outcome (endpoint), competing events and follow-up time 
The outcome was healing time. Healing time was defined as the time from the start of 
treatment in specialist health care to complete ulcer healing. Healing was defined as 
healing (intact skin) of the whole foot without minor or major amputations. Competing 
events were amputation and death. Follow-up time was defined as the time from the 
start of treatment in the outpatient clinic until ulcer healing, amputation or death, 
whichever came first. Minor amputation was defined as amputation below the ankle, 
while major amputation was above the ankle. 
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3.1.6 Statistical methods 
Mean, median and standard deviations (SD) were used for continuous variables, and 
counts and percentages for categorical variables. To test for associations between 
categories of duration of ulcer and severity of ulcer, Chi-square tests were used and     
t-tests were used for continuous variables. 
To calculate healing time of a DFU from start of treatment in specialist health care to 
healing, amputation or death, survival analysis was used. First, the cumulative 
incidence function was used to calculate healing time using the stcompet command in 
Stata with amputation and death treated as competing risk and calculated separately 
for: 1) duration of ulcer divided into two fractions, and 2) for the three combinations 
of grade and stage. Second, competing risk regression analysis by Fine & Gray (111, 
112) was used to calculate the association of duration of ulcer, ulcer severity classified 
according to the UT classification system with healing time, and also for the association 
between amputation and ulcer severity. Competing events were amputation and death, 
while loss to follow up was treated as censored observations (111, 112). Results were 
reported as sub hazard ratio (SHR) with 95% confidence intervals (CI). First, the 
associations between predictors, potential confounders and the outcome using 
univariate competing risk regression models, were investigated. Second, a model was 
constructed where the main exposures, the two fractions of duration of ulcer and ulcer 
severity were mutually adjusted. Finally, a multivariate competing risk regression 
model including potential confounders, such as sex, age, HbA1c, coronary disease, 
vascular surgical treatment and neuropathy was constructed, in addition to the two 
fractions of ulcer duration and ulcer severity. 
3.2 Study II 
3.2.1  Design 
To assess the effect of telemedicine follow-up care versus standard outpatient care for 
DFUs, we used a pragmatic cluster non-inferiority RCT (Clinicaltrials.gov: 
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NCT01710774) (Explanation of the terms pragmatic and non-inferiority is described 
on page 41-42). The trial protocol has been published previously (26). The patients 
were recruited from September 2012 to June 2016.  
3.2.2 Study sample 
Patients with diabetes-related foot ulcers referred to three hospitals in Western Norway: 
the Endocrinology Unit at Stavanger University Hospital, the Surgical Unit at Stord 
County Hospital and the Orthopaedic or Endocrinology Units at Haukeland University 
Hospital were included. 
Inclusion criteria were: Patients with type 1 or type 2 diabetes, aged 20 years or older 
with a new DFU. Excluded were patients who 1) had an ulcer on the same foot as the 
new ulcer during the previous 6 months before inclusion; 2) were unable to complete 
questionnaires in Norwegian; 3) had received a diagnosis of mental disorders or 
cognitive impairment (including schizophrenia, other psychotic disorders, and 
dementia); or 4) had a life expectancy of less than 1 year (26). 
3.2.3 Randomisation and Blinding 
Municipalities or districts in the municipalities in Hordaland and Rogaland County 
were divided into 42 clusters and matched in 21 pairs based on the population size and 
rural and urban characteristics of the municipalities or districts. A person not 
participating in the conduct of the study performed the randomisation using SPSS. 
After patient consent and baseline data collection, the patients were randomised to 
treatment with telemedicine follow up or to standard outpatient care based on the 
cluster they belonged to. All patients in each cluster were in the same treatment group 
and stayed in the study until ulcer healing, amputation or death, but maximum 12 
months (See Paper II consort flow diagram). 
3.2.4 Telemedicine intervention  
The follow up procedure for the intervention is shown in Figure 3. At baseline, all 
patients were diagnosed, an image of the foot ulcer was taken and the foot ulcer was 
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classified according to the UT classification system (12, 110). The community nurses 
received training in the telemedicine equipment during the 2 weeks after the patients 
were included in the study. The training consisted of written information about the 





The telemedicine intervention was asynchronous and consisted of an interactive web-
based ulcer record ‘®PleieNet’ and a mobile phone that facilitated the sending of image 
and text to the web-based ulcer record (26, 113) (Figure 4). Image and text were stored 
in the web-based ulcer record and transferred in an encrypted form to a server (113).  
Figure 3.The follow up procedure for the intervention 
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Figure 4. The telemedicine equipment; web-based ulcer record and mobile phone  
The patients received telemedicine follow up by the nurses in the community with 
consultations at the outpatient clinic every 6th week until an endpoint occurred, up to a 
maximum of 12 months. During follow-up time in the community, the community 
nurses communicated weekly with the expert team at the outpatient clinic by sending 
an image and written assessment of the foot ulcer via the mobile phone or e-mail to the 
web-based ulcer record. They received assessment, feedback and further follow-up 
procedure instructions from the expert team. If image and text were not recorded 
weekly by the community nurse, a reminder was sent by the expert team.  
Control group 
Patients in the standard outpatient care group received standard outpatient care 
provided by the outpatient clinic, usually scheduled to take place every second week 
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(26). The treatment procedures were evidence-based and based on the quality system 
at the hospital. 
3.2.5 Outcomes (endpoints) and competing events 
Primary outcome measure 
The primary outcome was healing time, defined as the time from the start of treatment 
in the outpatient clinic until the foot ulcer healed, but the maximum follow-up time for 
each patient was 12 months. Healing of the ulcer was defined as healing (intact skin) 
of the whole foot without any surgery (minor or major amputation) in the study period 
(26). 
Secondary outcomes 
Amputation was defined as minor or major amputations before ulcer healing. 
Death was defined as death before ulcer healing. 
Number of consultations per month of follow-up: For the telemedicine group each 
consultation at the outpatient clinic was registered in the web-based ulcer record. In the 
community care, the total number of consultations each patient received during follow 
up were documented in the web-based ulcer record by the community nurses.  
For the standard outpatient care group: Each consultation at the outpatient clinic was 
registered in the web-based ulcer record. If the patients needed follow up from the 
community nurses, health care providers at the outpatient clinic documented the total 
number of consultations during follow up. 
Patients’ experience: The Generic Short Patient Experiences Questionnaire (GS-PEQ) 
(114) was used to measure patients’ experience with either telemedicine follow up or 
standard outpatient care at the end of follow up. It consists of ten questions with a 
response score on a five point Likert scale ranging from 1-5 (1= not at all, 5=very 
strong degree). The Cronbach alpha for the 10 questions combined was 0.80. Question 
ten showed low item-to-total correlation and was therefore excluded before calculation 
of a mean satisfaction (experience) score for each patient. The patients completed the 
questionnaire at the end of the follow-up period. 
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3.2.6 Data collection  
Data were collected from medical records and the web-based ulcer record (®PleieNet) 
using a standard data collection form. The data collection started in September 2012 
and lasted until February 2017. The data collection on the last patient was completed 
on February 22nd 2017. The first author (HSS) participated in the data collection at 
Haukeland University Hospital. 
 At baseline (before randomisation), self-reported demographic data on age, sex, 
ethnicity, education, marital status, cohabitation and smoking status were collected. 
Clinical data on HbA1c, type of diabetes, localization of ulcer, classification of ulcers 
on the basis of the UT classification system, and micro vascular complications (as 
neuropathy and nefropati) macro vascular complications (angina pectoris, myocardial 
infarction, and stroke) were collected (26). 
Number of consultations per month of follow-up: See point 3.2.5 sub title secondary 
outcomes. 
3.2.7 Statistical methods 
The analyses were performed according to the protocol using the intention-to-treat 
analysis (26). We used mean and standard deviations (SD) for continuous variables, 
and counts and percentages for categorical variables. To test for the difference between 
groups on categorical variables, Chi-square test was used and t-test for continuous 
variables. A linear mixed effect regression to account for clustering in both groups was 
used to investigate differences in mean healing time among those patients whose ulcer 
healed, mean number of consultations per month and mean sum of a patient’s 
experiences. To test for differences in proportion of amputation and death we used a 
generalised linear model with log-link and binomial distribution. Cumulative incidence 
curves for healing were calculated for the telemedicine group and standard outpatient 
care group separately using the stcompet-command in Stata with amputation and death 
treated as competing events. Competing risk regression analysis by Fine & Gray, with 
robust standard errors to account for clustering, was used to calculate the differences 
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in healing time between the telemedicine and standard outpatient care, treating 
amputation and death as competing events (111). Results were reported as sub hazard 
ratio (SHR) with 95% confidence interval (CI) comparing the telemedicine and 
standard outpatient groups.  
In additional analysis, we used linear mixed model to test whether distance to the 
outpatient clinics affected the differences in consultations per months between the two 
groups. The model was also used to test whether there was an association between 
severity of ulcer and number of consultations per month. Further, to test whether there 
was a difference in number of consultations between the 3 hospitals within the 
telemedicine group.  
To determine the number of patients necessary, a power calculation was done. To 
detect a difference in mean healing time of 1.5 months (115) with 80% power, a 
significance level of 0.025, a standard deviation of 3.6 months (116) and an intra-class 
correlation coefficient of 0.02 and an average cluster size of 10 participants, the number 
of participants needed to be included was 217. Since we expected an attrition rate of 
5%, the number was set to 228, i.e. 114 patients in each group (26). 
The non-inferiority margin of 1.5 months was chosen based on the telemedicine 
consultations at the outpatient clinic being planned to take place every 6th week. If an 
ulcer healed between two consultations, health care personnel verified that the ulcer 
had healed at the subsequent consultation at the outpatient clinic. 
Thirteen patient did not receive telemedicine follow up due to 1) the patients did not 
want to receive follow up from the community nurses, 2) next of kin performed the 
treatment and 3) the ulcer was healed before the community nurses started follow up. 
All analyses were repeated (per protocol analysis) excluding the 13 patients in the 
telemedicine group who did not receive telemedicine follow up. 
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3.4 Study III 
3.4.1 Design  
Interpretive description as descried by Sally Thorne (117, 118), was used to explore 
experiences with telemedicine follow up and standard outpatient care in patients with 
DFUs delivered in a clustered RCT. The main objective of interpretive description is 
to provide knowledge that can have implications for nursing practice by giving 
methodological advice for developing such knowledge (117, 118).  
The method was first described by Thorne and colleagues in 1997 (119). Interpretive 
description builds on elements from grounded theory, ethnography and 
phenomenology. The goal for a study using interpretive description is that the research 
question should have implications for practice as well as originate from a deep 
understanding of what is known/unknown about the research area. The data collection 
and analysis should be performed concurrently, using constant comparative analysis. 
In this process, Thorne recommended avoiding premature coding. According to 
Thorne, clinical interpretability is not adequate with a ‘pure’ description of the results, 
and therefore the analytical process should seek to discover associations, relationships 
and patterns within the phenomenon that have been described (117, p. 50). Interpretive 
description does not require the study to be positioned with a formal theory (117, 118). 
3.4.2 Study sample 
Among patients participating in the cluster randomized non-inferiority trial, a 
purposive sample was chosen. We decided to use a heterogeneous sample, because we 
assumed that informants with different characteristics and experiences with 
telemedicine follow up and standard outpatient care might have different views about 
their treatment experience and in addition, would best be able to answer the research 
question (117, 118, 120). The inclusion criteria were patients who had completed the 
telemedicine intervention or standard outpatient care or were close to the endpoint 
(healed ulcer), who differed on their distance from the hospital, age, gender, education, 
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employment, material status and comorbid diseases and were able to participate in a 
one-on-one interview (able to consent, speak Norwegian).  
The study nurses at Stavanger and Stord Hospitals, responsible for the trial, organised 
patient recruitment based on the inclusion criteria previously described. The study 
nurse gave information about the interview and consent procedure. Patients who agreed 
to participate were contacted by the first author (HSS) to arrange the time and place for 
the interview.  
3.4.3 Data collection 
Individual interviews were used as the data collection strategy for this patient group, 
because we were interested in the individual experience with either telemedicine or 
standard outpatient care follow up. The first author (HSS) conducted all 24 interviews. 
The participant decided the time and place for the interview. Five interviews were 
conducted at the participants’ workplaces. The other interviews were conducted in the 
participants’ homes. Each interview lasted between 35 and 55 minutes. They were 
digitally recorded and each had a transcript prepared verbatim by the first author. The 
interviews were conducted over a period of 15 months between March 2014 and May 
2015. Twenty-four interviews were conducted (13 in the telemedicine group and 11 in 
the standard outpatient care group). There is no consensus on the number of 
participants needed to be included to ensure rich data. Saturation (119) or information 
power (121) are terms used to describe when sufficient participants are recruited. After 
including 24 participants, adequate saturation was researched. This was based on a 
continuous review of the interview findings, and saturation became clear when no new 
categories, themes or explanation emerge from the data. 
In order to compare and contrast the two groups, we kept the questions in the interview 
guide consistent and kept the core set of the questions as similar as possible for both 
groups. Exceptions were made for questions related to the patients’ experiences with 
health care professionals’ use of the telemedicine equipment and users’ own views of 
health care professionals’ use of digital images and remote assessment in wound care 
(Appendix 2). The interview guide was piloted with one patient from each group of the 
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trial to assess its usefulness and relevance of the questions. It was perceived as a 
functional tool with the need for only minor changes and the pilot interviews could 
therefore be included in the data material. 
3.4.4 Analyses  
According to the interpretive description strategy, the data collection and analysis of 
data should occur concurrently. The strategy does not provide the researcher with a 
‘cookbook’ of how the data material should be analysed because use of a ‘cookbook’ 
approach might limit the researcher’s creativity in the analysis process (117). 
Interpretive description allows for different analysis techniques, as long as the choice 
of the analysis technique is based on the research questions and the analytic process is 
logical and transparent. Important in the analysis process is creativity and intuition, and 
Thorne therefore recommend avoiding detailed coding at the beginning of the analysis 
process, because stricter coding might cause loss of valuable insight . A wider focus 
can prevent premature coding (117). 
The analysis process comprised four phases: (1) researchers’ immersion in the 
transcripts, (2) coding and developing of themes, (3) comparing and contrasting themes 
within the groups, and (4) comparing and contrasting themes between the groups 
(telemedicine/ standard outpatient care). Phase one started right after each interview 
field notes were taken. These field notes helped in the further analyses of the data, 
because they illuminated reflections on issues that arose during the interviews. In an 
ongoing process during the data collection period, the interviews were transcribed by 
the first author and read repeatedly in order to become familiar with the data. All 
transcripts ended up with tentative topics and preliminary interpretations of the text 
that were used in the further analysis process. In this process, the data material was 
read and discussed with the co-authors. During the analyses, it was important to be 
aware of one’s own pre-understanding, personality and experiences that could 
influence the analysis process (117, 120). In the next step, the initial coding started 
with an inductive approach and the coding was broad-based to avoid premature closure. 
We chose codes that matched closely to the language inherent in the data. The codes 
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that seemed thematically related were then placed together. Different tentative themes 
were identified and used in the further analysis. In the next step, we used a constant 
comparison approach to compare data and patterns within every interview and between 
interviews. This approach was used for within-group comparisons and between-group 
comparisons to identify similarities and differences. During this process, questions 
were asked as to what we saw in the data material, but also attention was given to what 
we might not have seen which could be important. Finally, comparing and contrasting 
these patterns within and between the groups enabled us to identify themes that were 
common. 
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 Ethical and legal issues 
The studies were performed in accordance with the ethical principles stated in the 
Declaration of Helsinki and were approved by the Western Norway Regional 
Committee for Medical and Health Research Ethics (REK2013/2327;                         
REK 2001/1609).  
Study I 
Project number, Western Norway Regional Committee for Medical and Health 
Research Ethics: 2013/2327. 
Written informed consent was required from all participants alive at inclusion. The 
participants were invited by letter to participate in the study. They were informed that 
active participation was not required, only consent to obtain information from medical 
records. All participants were informed about the meaning of voluntary participation, 
that is, their right to withdraw from the study at any time without any consequence for 
or influence on further treatment and care at the hospital. Further, they were informed 
about anonymisation and confidentiality of the data collected. If participants had any 
question related to the study, questions could be addressed to the project manager by 
phone or email. 
We followed the STROBE Statement: guidelines for reporting observational studies 
(122).  
Study II 
Project number, Western Norway Regional Committee for Medical and Health 
Research Ethics: (2011/1609).  
Participation was voluntary and written informed consent was required. All participants 
were informed about the meaning of voluntary participation, that is, their right to 
withdraw from the study at any time without any consequence for or influence on 
further treatment and care at the hospital. Further, they were informed about 
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anonymisation and confidentiality of the data collected. Participating in the study did 
not raise problematic or specific ethical issues. 
The Norwegian Centre for Integrated Care and Telemedicine was the Counselor 
according data security and legal aspects of the project. Data controller agreements 
were established between all involved parties according to Norwegian legislation and 
security services. Risk assessment analysis after the pilot project and during the study 
period was conducted. 
To improve the clarity, accuracy and transparency of our trial report we followed the 
CONSORT flow diagram extension to cluster randomised trials (123) together with the 
CONSORT checklist for non-inferiority and equivalence randomized trials (124).  
Study III 
Study 3 involved collection of new data from a subsample of patients involved in the 
RCT. Permission was given by the Western Norway Regional Committee for Medical 
and Health Research Ethics (2011/1609). Relevant participants were contacted by the 
study nurse who asked if they would be willing to participate. If they agreed, a formal 
appointment for an interview was obtained. Written consent was required by the 





 SUMMARY OF THE RESULTS 
5.1 Study I 
Severity and duration of diabetic foot ulcer (DFU) before seeking care as 
predictors of healing time: A retrospective cohort study. 
Of the 105 patients included in this cohort, 45.7% achieved complete ulcer healing, 
36.2% underwent amputation, 9.5% died before healing and 8.5% were lost to follow 
up (Figure 1, p. 19). The median follow-up time measured from start of treatment in 
specialist health care to end of follow up for the total sample (including those who 
healed, amputated, died and lost to follow up) was 67 days (2.2 months). Mean follow- 
up time was 130 days (4.3 months). The median time measured from start of treatment 
in specialist health care to ulcer healing for those who healed was 75.5 days (2.5 
months). Mean healing time was 113 days (3.8 months). Baseline characteristics of the 
patients and baseline characteristics of severity of ulcers are shown in Tables 3 and 4. 
 
Characteristics  Total 
(n = 105) 
Demographic variables  
     Male sex, n (%) 74 (70.5) 
     Age (years) mean, (SD) 68.7 (±14.8) 
Diabetes type   
     Type II, n (%) 83 (79.0) 
Disease-related variables  
     Insulin treatment, n (%) 68 (64.8) 
     HbA1c  (mmol/L), (SD) 63  (±17.5) 
     HbA1c   (% units),  (SD) 7.9  (±1.6) 
Localization of ulcer, n (%)  
     Toe 64 (61.0) 
     Metatarsal/plantar 19 (18.1) 
     Heel 22 (21.0) 
Comorbidities  
    Coronary diseases, n (%)  48 (45.7) 
    Neuropathy, n (%) 69 (65.7) 
 
 
Table 3. Baseline characteristics of patients with                                           
a diabetic foot ulcer 
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Stage   Grade 0 Grade 1 Grade 2 Grade 3 Total 
A Clean wound - 16 (15.2) 1(1.0) 1 (1.0) 18 (17.1) 
B PAD -, infection + - 8 (7.6) 10 (9.5) 11 (10.5) 29 (27.6) 
C PAD +, infection - - 8 (7.6) 5 (4.8) 6 (5.7) 19 (18.1) 
D PAD +, infection + - 5 (4.8) 10 (9.5) 24 (22.9) 39 (37.1) 
Total, n, (%)  - 37 (35.2) 26 (24.8) 42 (40.0) 105 (100) 
PAD: Peripheral arterial disease 
Grade 0: Pre-or post-ulcerative lesion, Grade 1: Superficial wound, not involving tendon, capsule or bone, Grade 
2: Wound penetrating to tendon or capsule, Grade 3: Wound penetrating to bone or joint 
 
Thirty-eight point one percent of the patients had had an ulcer ≥ 60 days before the 
start of treatment in specialist health care, where 31.4% of the patients had had an ulcer 
52 days or more from patient-reported ulcer onset to referral by GP to specialist health 
care. Thirty-four point three percent of the patients waited more than 14 days before 
start of treatment at the specialist health care after referral from the GP. Of patients 
classified in grade 3/stage D, 10 patients underwent minor amputation and 10 major 
amputation. 
In the unadjusted univariate competing risk analyses, we found that there was a 
significant association between time from patient-reported ulcer onset to referral by a 
GP to specialist health care and healing time (SHR 0.33, CI 0.15, 0.72), but no 
association between referral from a GP to specialist health care and healing rate was 
found (SHR 1.30, CI 0.61, 2.76). In the adjusted multivariate competing risk analysis, 
these associations were maintained. We found that patients who had a duration of ulcer 
≥ 52 days from patient-reported onset of ulcer until referral by a GP to specialist health 
care had 58% decreased healing rate compared with patients who were referred earlier 
(SHR 0.42, 95% CI 0.18, 0.98) in the adjusted model. There was no association 
between time from referral from GP to start of treatment in specialist health care and 
healing rate (SHR 1.84, 95% CI 0.70, 4.84). 
For ulcer severity, we found that patients with ulcers of the highest stage and grade had 
86% decreased healing rate compared with ulcers of low severity, after adjusted for 
referral time and other potential confounders (SHR 0.14, 95% CI 0.05, 0.43). 
Table 4. Ulcer characteristics at baseline according to University of Texas classification of 





5.2 Study II 
The Effect of Telemedicine Follow-Up Care on Diabetes-Related Foot Ulcers: A 
Cluster Randomized Controlled Non-Inferiority Trial 
In total, 142 of 182 patients in the trial obtained complete healing: 75 (79.8%) in the 
telemedicine group and 67 (76.1%) in standard outpatient care group, respectively. 
Mean healing time for those who healed was 3.4 months in the telemedicine group and 
3.8 months in the standard outpatient group. Baseline characteristics of the patients and 




(n = 182) 
Demographic variables  
     Male sex, n (%) 135 (74.2) 
     Age (years), n (±SD) 66.4 (±16.6) 
Subgroups of diabetes   
     Type 2 diabetes, n (%) 144 (79.1) 
Diabetes-related variables  
     Insulin treatment, n (%) 116 (64.4) 
     HbA1c (% mmol/L), n (±SD) 62 (± 18.6) 
     HbA1c (% units), n (±SD) 7.8 (±1.7) 
Ulcer characteristics  
Localization of ulcer, n (%)  
  Toe 91 (50.0) 
  Metatarsal/plantar (study 1), Metatarsal  (study II) 27 (14.8) 
  Heal  16 (8.8) 
  Other  48 (26.4) 
Cardiovascular disease n (%) 56 (31.6) 








Table 5. Baseline characteristics for the total sample of patients                                         
with a diabetic foot ulcer 
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Stage           Telemedicine   Standard outpatient care 
                    (n = 94)   (n = 88)  
  Grade 1 Grade 2 Grade 3  Grade 1 Grade 2 Grade 3 
A Clean wound 29 (30.0) 2 (2.1) 0 (0.0)  34 (38.6) 2 (2.3) 0 (0.0) 
B PAD -, infection + 27 (28.7) 3 (3.2) 4 (4.3)  19 (21.6) 2 (2.3) 7 (8.0) 
C PAD +, infection - 14 (14.9) 1 (1.1) 1 (1.1)  14 (15.9) 3 (3.4) 2 (2.3) 
D PAD +, infection + 7 (7.4) 4 (4.3) 2 (2.1)  1 (1.1) 0 (0.0) 4 (4.6) 
PAD: Peripheral arterial disease 
Grade 0: Pre-or post-ulcerative lesion, Grade 1: Superficial wound, not involving tendon, capsule or bone, Grade 2: Wound 
penetrating to tendon or capsule, Grade 3: Wound penetrating to bone or joint 
 
For the primary outcome, we found that telemedicine was non-inferior to standard 
outpatient care regarding healing time (mean difference -0.43 months, 95% CI -1.50, 
0.65). Competing risk regression analysis showed no statistical differences between the 
groups in healing time (SHR 1.16, 95% CI 0.85, 1.59).  
The analysis for the secondary outcomes showed significantly fewer amputations in 
the telemedicine group compared with standard outpatient care, 6 (6.4%) and 13 (14.8), 
respectively, (mean difference –8.3% with 95% CI –16.3%, –0.5%). 
There were no significant differences in the proportion who died between the two 
groups, 5 (5.3%) in the telemedicine group and 5 (5.7%) in the standard outpatient 
group, respectively, (mean difference -0.4%, 95% CI -6.5%, 5.7%). 
The number of consultations per month for the telemedicine group and standard 
outpatient group at the outpatient clinic was not significantly different, 2.0 and 2.5 
consultations per months, respectively. The consultations were in favour of 
telemedicine group (mean difference -0.48 consultations per month, 95% CI –1.46, 
0.49).The additional analyses showed that the hospital that was included first in the 
intervention showed significantly lower number of consultations per months within the 
telemedicine group compared with the hospital that was included last (mean difference 
-1.1, 95% CI -2.2,-0.1). 
Within the telemedicine group, patients who lived more than 25 km from the outpatient 
clinic had significantly lower number of consultations per months compared to those 
who lived ≤ 25 km from the outpatient clinic  (mean difference -1.0, 95% CI -1.9,-0.1). 
Table 6. Ulcer characteristics at baseline according to University of Texas classification 
system by treatment groups 
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There were also significantly fewer consultations per month in the telemedicine group 
compared to the standard outpatient care group when the analyses was restricted to 
patients living >25 km from the outpatient clinic (mean difference -1.2, 95% CI -2.4,  
-0.03). 
Patients in both groups reported high satisfaction with the treatment and follow up and 
there were no significant differences between the two groups (mean difference 0.07, 
95% CI -0.10, 0.24).  
5.3 Study III  
An integrated wound-care pathway, supported by telemedicine, and competent 
wound management-Essential in follow-up care of adults with diabetic foot ulcers.  
An important requirement expressed by the patients was to feel secure about or have 
confidence in the treatment and follow up. From the interpretive description analysis, 
three themes emerged: competence of health care professionals, continuity of care, and 
easy access to health care. Type of follow up (telemedicine versus standard outpatient 
care) appeared to be less important in terms of the patients’ follow-up experiences. The 
competence of health care professionals and continuity of care were essential because 
these two factors had the capacity to either strengthen or threaten high-quality foot 
ulcer care. If these two factors were absent among the home care nurses, the patients 
felt that they lost confidence in the wound care process. If this happened, patients 
pointed out that the expert knowledge from health care professionals in the outpatient 
clinic turn out to be an essential confidence factor for them, and was necessary to 
receive good foot care. When telemedicine functioned as intended, the analysis 
revealed positive process with use of telemedicine follow-up. This was related to that 
use of an image with the mobile phone could rapidly capture changes in the healing 
process. By forward the images to the expert team at the outpatient clinic this allowed 
both the home care nurse and the expert team to evaluate the ulcer and discuss 
necessary treatment cause. Easy access and proximity to the service were important for 
the patients. Follow up of the home care nurse was a relevant care pathway if the home 
40 
care service was available and of sufficient quality i.e. competence among home care 
nurses and continuity of care. If these two factors were presented, the patients preferred 
to receive follow-up from the home care nurses because treatment close to home 
provided flexibility in choosing time and place for treatment and thus limited travel 
time and waiting time at the outpatient clinic. 
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 DISCUSSION 
The overall aim of this study was to provide new knowledge about predictors of healing 
time in patients with a DFU and to assess the effect of and experience with a 
telemedicine intervention in patients with a DFU. More evidence is needed on 
alternative care pathways to follow-up DFUs and this RCT (paper II) is the second in 
the world investigating the effect of a telemedicine intervention on people with DFUs. 
The first part of this section considers strengths and limitations of the methodologies 
used in the three studies. In the second part, the main findings will be discussed. 
6.1 Methodological considerations 
6.1.1 Study design  
A retrospective cohort study design, as used in Study I, is appropriate for describing 
associations between variables and was used to describe the association between 
duration of ulcer with healing time and ulcer severity with healing time. The design is 
characterised by the exposure and outcome having occurred in the past (exposure 
occurring before the outcome) and data having been collected from existing records, in 
this case electronic medical records (125). The strength is that the patients were 
followed over time, from start of treatment to the endpoint. We extracted data from the 
electronic medical records from 2009 to 2011and then followed the cohort forward in 
time to investigate the influence of the exposures (i.e. duration of ulcer and severity of 
ulcer) on the outcome (i.e. healing time). This research design allowed the description 
of observed associations but a limitation is that caution should be exercised in inferring 
this to be evidence of cause and effect. 
To evaluate the effect of the telemedicine intervention, we used a pragmatic cluster 
randomised controlled non-inferiority trial in Study II. The design is a parallel cluster 
design that compares the results of a specific intervention (telemedicine follow up) with 
standard outpatient care used for the control group. This prospective and experimental 
study is characterised by the independent variable being manipulated and controlled by 
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the researcher and the dependent variables being collected under controlled conditions 
(126). However, this pragmatic trial investigating the telemedicine intervention in daily 
clinical practice at three clinical sites may lead to less control of the intervention and 
outcomes variables due to lack of blinding of the health care professionals and the 
patients (127).  
The main advantage of an RCT compared to a cohort study is that causal relationships 
may inferred, albeit with some limitation regarding external validity of the findings 
from the RCT. A pragmatic trial approach may increase the external validity and 
generalisability of the results, because pragmatic trials measure the effect of the 
intervention in a real-life setting (127). 
A non-inferiority approach was decided based on the expectation that telemedicine 
follow-up care would be no worse than standard outpatient care in terms of ulcer 
healing time. A non-inferiority approach is of interest from the premise that the new 
treatment has some other advantages than the standard or reference treatment (124). 
Telemedicine follow up may have the advantage that it might be preferable to standard 
outpatient care given that it may lead to more integrated care, allow more patients to 
be treated in or near their home, and thus contribute to more flexible health care 
services.  
A cluster RCT is characterised by randomisation at group or cluster level and is used 
when it is difficult to apply an experimental intervention to individual subjects (128). 
The rationale for choosing a cluster RCT was that a classic RCT could threaten the 
internal validity of the findings. We therefore randomised municipalities and districts 
within municipalities (organisational units) to avoid that the community nurses treated 
patients in both the telemedicine and standard outpatient care groups, which could 
threaten the internal validity (26).  
The rationale for choosing a qualitative approach in study III was to get in-depth 
knowledge of patients’ experiences with receiving either follow up or standard 
outpatient care beyond the actual effect goals in the cluster non-inferiority RCT. The 
strength of a qualitative design is that data are collected in a real world setting, but a 
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weakness with the use of qualitative data is reduced generalizability of the findings 
(120). An additional limitation was that the data were collected only from two of the 
three clinics that were involved, making the conclusion not fully reflective of the whole 
picture. However, qualitative information can be an important supplement information 
in helping to evaluate whether use of telemedicine may be an alternative care pathway 
for patients with DFUs. 
6.1.2 Internal validity (Paper I and II) 
Internal validity in quantitative designs refers to the extent to which the results of the 
study demonstrate a cause-effect relationship between the independent and dependent 
variables (125). In a non-experimental study, like Study I, internal validity measures 
the extent to which the independent variable is a possible explanation for the 
relationship with the dependent variable (129). In experimental research, as in Study 
II, this means that the intervention causes the change in the dependent variable (130). 
The reporting of the studies are in line with the CONSORT statement: STROBE 
Statement for Study I (122), and CONSORT 2010 for the cluster randomised trial 
(123); CONSORT Statement 2006 for Non-inferiority and Equivalence Trials for 
Study II (124), which are intended to improve the reporting of trials and minimising 
the risk of bias. 
Retrospective cohort study – Study 1 
The internal validity in the retrospective cohort study is dependent mostly on issues 
such as confounding, selection bias, information bias and sample size. In cohort 
studies, randomisation is not applicable and controlling for confounders is therefore 
important (129).  
A confounding variable, can affect the association between the independent variable 
(exposure) and dependent variable (outcome) that can affect the results (129). Support 
for confounding occur if we find that: 1) the potential confounder is associated with 
the exposure factor, 2) independently associated with the outcome, and that 3) the 
variable cannot be an intermediate between exposure and the disease (129). To adjust 
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for possible confounding different multivariable statistical techniques can be used such 
as multivariate regression analysis. Potential confounders should be identified a priori 
based on the knowledge of the field. Six potential confounders were identified a priori 
based on previous knowledge and before the statistical analysis. Age, sex, HbA1c, 
neuropathy and comorbidity such as coronary diseases are often well known 
confounders in the association between the exposure and outcome (11) and are often 
adjusted for in multivariate analyses. An additional argument for including neuropathy 
was that neuropathy is not included in the UT classification system, which has been 
emphasised as a limitation of the system (14, 65). Vascular surgery treatment as a proxy 
for peripheral arterial disease is less frequently assessed as a potential confounder (11), 
but it can be an important predictor in ulcer healing if the treatment leading to increased 
blood flow in the lower extremities is improved. The univariate analysis revealed that 
age and vascular surgery treatment were potential confounders in the association 
between duration of ulcer and healing time. These variables were associated with 
reduced healing time. We therefore adjusted for age and vascular surgery treatment in 
the multivariate competing risk analysis but also included the other potential 
confounders. In the adjustment analysis these association did not remain significant. 
Selection bias is a result from the procedure used to select participants and from factors 
that influence study participation leading to a systematic error (129). Due to our 
sampling method, risk of selection bias may have occurred. In total, 30.5% of the 
eligible patients did not consent to participate. Non-participants might have been in 
worse health compared with participants, which could potentially have led to selection 
bias. Therefore, the increased healing time associated with duration of ulcer before start 
of treatment in specialist health care and severity of ulcer might have been under-
estimated. On the other hand, patients might have had worse health when they were 
asked to participate, which in this retrospective study means at the end of the study. 
This does not mean that the overall health of the patients at the starting point was worse. 
We also excluded patients treated for foot ulcers during the previous 12 months. An 
under-representation of patients with chronic ulcers may have resulted in an under-
estimation of the association between severity of ulcer and healing time. Altogether, 
this might have led to a selection bias, with our sample representing less severe ulcers. 
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Information bias can result from systematic errors concerning information documented 
in the electronic medical records that can lead to incorrect measurement in the exposure 
or outcome variable (129). Electronic medical records were used to collect data on the 
patients. We can assume that objective data such as disease-related variables, ulcer-
related variables and the demographic variables of age and gender are reported 
reasonably accurately in electronic medical records. In Study I, we used patient-
reported data on duration of the ulcer, which might be more inaccurate, as patients with 
neuropathy can have an ulcer without being aware of it. This might have under-
estimated the association between duration of ulcer and healing time. 
The sample size in Study I is relatively small, increasing the risk of type II error, i.e. 
failing to find statistically significant results even though there is an association 
between the variables in the population from which the sample was drawn (125). Of a 
total cohort of 151 patients registered between 2009 and 2011 at the two hospitals, 105 
patients were included in our study. However, despite a small sample size, our findings 
showed that duration of ulcer and severity of ulcer were significantly associated with 
healing time after controlling for confounders. 
Experimental design – Study 2 
An experimental design, due to its manipulation of the independent variable, control of 
the experimental situation and randomisation, is considered to be the design that has 
most robust internal validity (130). However, different threats to internal validity and 
statistical conclusion validity need to be considered. 
Selection bias may be a treat to internal validity. Selection bias in an experimental 
design refers to systematic differences in baseline characteristics between the two 
groups (126). Selection bias is usually ruled out in an RCT if successful randomisation 
occurs, but consideration of selection bias should nevertheless be given (130, 131). 
Randomisation at the cluster level can cause differences in the groups. We found that 
the baseline characteristics between the two groups were overall well matched except 
for a significant difference in localization of the ulcer and type of diabetes between the 
two groups. More patients in the telemedicine group had an ulcer in the toe region 
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compared with the standard outpatient group. Since the clusters in our study were 
relatively small, this might explain the difference in ulcer location between the two 
groups. However, when we adjusted for ulcer localization with healing time in the 
linear mixed effect regression model, the difference between the groups was still non-
inferior (unadjusted: mean diff -0.43 (CI -1.50, 0.65) and adjusted: (mean diff -0.19 
(CI -1.28, 0.90). In addition, in competing risk analysis with ulcer healing as the 
endpoint adjusted for ulcer localization, SHR did not change much (SHR 1.13, 95% CI 
0.83, 1.57). A higher proportion of patients in the telemedicine group had type 2 
diabetes, but the proportion of patients using insulin in both groups was not statistically 
different, indicating similarities in severity of diabetes between the groups. Due to 
these explanations, we consider the risk of selection bias caused by randomisation to 
be low. 
 In the analyses of mean healing time we included only those who healed in the two 
groups, excluding those who died or amputated and those who had not achieved ulcer 
healing after 12 months. This was necessary since it does not make sense to measure 
healing time for an ulcer which did not heal, but it may have led to some degree of 
selection bias since the amputation rate was higher in the standard outpatient care 
group. To account for this we also did competing risk regression where all patients 
were included. But since we had not decided upon an a priori non-inferiority margin 
for the confidence interval of the SHR we could not investigate non-inferiority in the 
competing risk analysis. We could thus only test for significant differences. Ideally, a 
non-inferiority margin should have been set a priori also for the SHRs, but it is difficult 
to select clinical relevant margins for a relative measure. 
Another treat to internal validity is attrition bias which refers to a situations where 
patients in the experiment fail to complete some or all of the outcome measures (131). 
Thirteen patients in the intervention group did not receive the telemedicine intervention 
as intended in primary health care. Such occurrences can underestimate the effect of 
the intervention, since some patients did not get the assigned treatment (125). To test 
for this, we therefore repeated the analysis as a per-protocol analysis, excluding the 13 
patients in the telemedicine group, and found that the results were approximately the 
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same. Therefore, we considered the risk of attrition bias to be low. There was also no 
attrition of clusters in the study.  
Further, performance bias is a systematic difference in the care provided to patients 
between groups or in exposure to factors other than the intervention of interest (131). 
In the RCT, we could not blind the health care professionals at the outpatient clinics 
who delivered the intervention. This may have affected the number of consultations at 
the outpatient clinics or caused fewer amputations to be performed in the telemedicine 
group compared with the standard outpatient care group. We consider the risk of 
performance bias to be high. 
Detection bias, is also a treat to internal validity, refers to a systematic difference 
between groups in how outcomes are determined (131). As we did not blind the 
patients, researcher and outcome assessors, the risk of detection bias increased.  
In addition, time is an important factor to consider, as the real world setting will change 
during a 5-year trial that can be referred as history bias (126). During this period, the 
pressure on the health care system might have increased and consultations might have 
been delayed or re-scheduled more often. Another aspect is that even though we used 
the same technology throughout our trial, technology is continually developing and as 
more sophisticated technology is now available, this needs to be considered when 
generalising the findings. 
Statistical conclusion validity concerns whether the presumed cause and effect covary 
and how strongly they covary and two types of error: type I and II, that can occur (130). 
Type 1 error can occur if we conclude that cause and effect covary when they do not 
or conclude that they do not covary when they do (type II error) (130). To prevent type 
1 errors occurring, the type I error rate is usually set to α = 0.05 (130), but in a non-
inferiority trial, it is set to α = 0.025. This implies that 5% or 2.5% of the co-variation 
will occur by chance. 
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There are many potential threats to statistical conclusion validity and some of these are 
relevant to this study: 
Low statistical power is one important factor that can threaten statistical conclusion 
validity (130). With low statistical power, the risk of type II errors increases. One way 
of ensuring adequate statistical power is to estimate the sample size needed by using 
power analysis. Estimated sample size based on power analysis in Study II was 217 
(26). We managed to include a total of 182 patients. The lower sample size in this study 
compared with estimated sample size may have prevented us from detecting significant 
differences between the groups. However, all effect estimates for the secondary clinical 
outcomes favored the telemedicine group, indicating that a larger sample size would 
not have resulted in any differences in favour of the standard outpatient group.  
Unreliability of treatment implementation is another factor related to statistical 
conclusion validity. It refers to whether the intervention is implemented inconsistently 
(125). In this pragmatic trial, different outpatient clinics, different municipalities or 
districts within the municipalities provided the intervention, and it is unlikely that all 
the health care professionals conducted the intervention in a similar manner in and 
across all the communities. However, to ensure that the health care professionals 
involved in the intervention received similar training, the training received from the 
specialist clinic was standardised and all involved in the intervention used the same 
guidelines. We considered the risk of unreliability of treatment implementation bias to 
be moderate. 
Statistical conclusion validity can also be influenced by restriction of range (130). We 
used one instrument for evaluating patients’ experience with receiving telemedicine 
follow up versus standard outpatient care. The positive experience with the treatment 
and follow up found in both groups in this study measured by GS-PEQ might be caused 
by a ceiling effect. This may indicate that the instrument chosen was not sensitive 
enough since most patients were clustered near the highest score. 
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6.1.3 External validity (Paper I and II) 
External validity in quantitative research is the ability to generalise study results to the 
target population (129, 130), while generalisation in qualitative design refers more to 
the degree to which the findings can be transferred to other contexts (117, 118, 120). 
The target population for all three studies was patients with a DFU referred to specialist 
health care in Norway. Approximately 19% of the Norwegian population lives in 
Rogaland and Hordaland counties were the patients were recruited from. Both counties 
serve patients from urban and rural areas. The composition of the inhabitants with 
respect to age and sex in Rogaland and Hordaland counties are very similar to that of 
the overall population in Norway. It is therefore reasonable to believe that the people 
with a new diabetic foot ulcer in Rogaland and Hordaland do not differ from patients 
referred to specialist health care in other counties in Norway. The study sample in 
Studies I and II are ethnically homogeneous, indicating that our results may not be 
representative of other ethnic groups. 
Our cohorts in Studies 1 and 2 seem to correspond well to other cohorts both nationally 
and internationally (9, 35, 46, 47, 95, 132) with respect to baseline characteristics such 
as age, sex, types of diabetes, which can indicate that our sample can be representative 
of the target population being studied. However, in Study II, we excluded patients if 
they had mental disorders or cognitive impairment (including schizophrenia, other 
psychotic disorders), an inability to complete questionnaires in Norwegian and a life 
expectancy of less than 1 year,- limitations that might have reduced its 
representativeness.  
6.1.4 Credibility in the qualitative study (Paper III) 
To judge the credibility of the qualitative research, Thorne (117, 118) suggests several 
criteria: epistemological integrity, representative credibility, analytic logic, interpretive 
authority, moral defensibility and pragmatic obligation.  
Epistemological integrity refers to demonstrating a logical coherence throughout the 
entire research process, from the research question, to the interpretation of data and use 
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of analytical strategies (117). Our research question in Study III focused on exploring 
patients’ experiences with telemedicine follow up and standard outpatient care to 
promote knowledge gained from patients’ perceptions about whether use of 
telemedicine could be an alternative way to improve wound care management for 
patients with DFUs and thus have implications for clinical practice. This is consistent 
with interpretive description where the results should have implications for clinical 
practice, without demanding that the findings be true for all patients receiving 
telemedicine follow up or standard outpatient care. The results of the current study 
showed that the patients’ experiences varied, which needs to be taken into 
consideration when determining whether telemedicine is a possible care pathway for 
patients with DFUs. The analytical strategy chosen for interpreting the data must also 
be logical from the research question and be in agreement with the principle of 
interpretive description (117). To explore our research questions, patients with 
different characteristics were invited to participate. To fully meet the constant 
comparative method, data collection and analysis of data occurred simultaneously. 
Using a constant comparative analysis approach enabled us to explore similarities and 
differences within the groups and between the groups. This interpretive description 
approach made it possible to generate patterns and themes that gave us insights into 
issues important in wound care for patients with DFUs.  
To achieve representative credibility, the results reported must be consistent with the 
sampling strategy chosen (117). We chose a sampling strategy that selected patients 
who could most benefit from the study. We chose to include patients with diverse 
backgrounds and who lived at different distances from the outpatient clinic to ensure 
maximum variation and comparability, which we assumed was relevant for their 
experiences. What is considered an appropriate sample size in qualitative design is 
debated (117, 120). However, rather, to claim saturation, a good rule is to follow a 
strategy that ensures information strength in the sample through gradual recruitment 
and analysis (117, 120).We stopped including patients when new categories, themes or 
explanation stop emerging from the data. Nevertheless, it is difficult to be sure, whether 
the sample size is large enough, but it is important to have in mind that the findings 
may have been different if a larger sample had been interviewed. However, only two 
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out of three clinics were involved in the supplementary studies, and therefore, this 
conclusion may not apply to the clinic that attended the trial in 2015.  
Thorne recommended the use of an audit trail to facilitate transparency, referred to as 
analytic logic (117, 118). An audit trail is an adequate description of the different steps 
and decision-making taken throughout the entire research process that should make it 
possible for other researchers to assess the process. The data collection method and the 
analysis phases are described in more detail in section 3.4.3 and 3.4.4 page 30-31 and 
in paper III. 
Interpretive authority is related to credibility of the interpretation (117, 118). The 
analysis process is influenced by the researchers’ backgrounds and prior understanding 
and the researchers need to be aware of this in the analysis process. To achieve 
credibility of the interpretation each author analysed the data individually, after which 
they came together to discuss the data. By doing so, it was possible to obtain a 
consensus of the interpretation of the patterns and themes that emerged during the 
analysis process. Important in this process was the collaboration with experienced 
researchers with extensive experience in qualitative analysis. A challenge in the 
process was the term broad-based coding that in the beginning of the coding process 
was not clear, but an understanding of the term broad-based coding arose during some 
rounds of coding. In addition, the level of interpretation and to what level the data 
should be abstracted during the analysis process presented challenges, but the aim of 
the study and the relevance for clinical practice underpinned the process.  
Moral defensibility refers to that the researcher must know why the knowledge is 
necessary and the purpose with such knowledge (118, 119). The care pathway for 
patients with DFUs has not be optimal. There are indications that patients with DFUs 
are treated for a substantial length of time in primary health care with limited continuity 
of care, few specialist nurses and lack of integrated care between health care levels (92, 
93).  In additional, the increased pressure at the health care system to deliver care to 
patients has required new approaches to organising the health care system. Therefore, 
we decided to investigate whether use of telemedicine could achieve a more 
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coordinated and integrated health care and thus be an alternative care pathway for this 
patient group. As a result of the findings, this study has provided new knowledge and 
insight beneficial to further discussions as to whether use of telemedicine could be an 
alternative care pathway for patients with DFUs and thus facilitate flexibility in wound 
care.  
Pragmatic obligation is also mentioned by Thorne as a credibility indicator, described 
as a duty or obligation to the researcher to consider the findings “as if” it might be used 
in practice (118). It was therefore of importance to construct a study that should have 
implication for the clinical field and thus be enable to maintain the moral mandate to 
produce knowledge that could be useful in the clinical field. 
6.2 Discussion of the results 
6.2.1 Predictors of ulcer healing  
Duration of ulcer 
Although the importance of early referral of DFUs to specialist health care to prevent 
severe complications is emphasised in national and international guidelines (59, 61, 
62), this recommendation needs more attention in clinical practice. This is underlined 
by our study as many patients with DFUs seemed to have been delayed in being 
referred to specialist health care (9, 63). Findings from Study 1 showed that 38.1% of 
the patients had a 60 days or longer duration of ulcer prior to the start of treatment in 
specialist health care. Our study showed a strong association between delayed referral 
to specialist health care and healing time after adjustment for potential confounders. In 
contrast to previous studies, we assessed different fractions of the referral pathway in 
addition to the total period (Figure 2, Page 20). We found that the interval from patient-
reported ulcer to referral by a GP to start of treatment in specialist health care was the 
main contributor to the association. Patients who were referred by a GP to specialist 
health care 52 days or more after ulcer onset had 58% decreased healing rate compared 
with those who were referred earlier. Our results reinforce previous evidence that early 
referral to specialist health care when an ulcer has occurred is important (9, 63). 
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Although we found that the interval from patient-reported ulcer to referral by a GP to 
start of treatment in specialist health care showed an association with healing time, we 
do not know how long patients waited before contacting the GP. Nor do we know how 
long the GP treated the ulcer before referral to the specialist health care. Such 
information could provide valuable information about what causes the delayed referral 
to specialist health care, so more in-depth research is needed. 
The GP plays an important role in the follow up of patients with DFUs and in 
systematic risk assessments of ulcers and feet. The GP serves as a ‘gate keeper’ to 
specialist health care (87), and is responsible for an adequate referral practice in order 
to ensure appropriate treatment at the right place at the right time (133). National and 
international guidelines recommend that patients with diabetes who have infected 
ulcers, ulcers combined with ischaemia or neuropathy, previous foot ulcers, as well as 
recurrence of wounds, should be referred to the specialist health care service quickly 
with follow up by a multidisciplinary team (59, 61, 62). Early referral to specialised 
multidisciplinary foot teams offers good opportunities to treat foot ulcers that 
contribute to a more systematic treatment, shorter healing time and fewer amputations 
(134, 135). However, as of today, none of the multidisciplinary teams in Norway carry 
out consultations or supervision in the municipal health service (91). Thus, a closer 
collaboration between these two health care levels is important. A low threshold among 
GPs to confer with multidisciplinary teams regarding foot problems in high risk 
patients should therefore be highlighted (25, 59). The National Guideline for Diabetes 
encourages the use of telemedicine solutions to improve the service (59). Recent 
research showed that the use of telemedicine in treatment and follow up of patients 
with DFUs can contribute to a streamlined communication and collaboration between 
the two levels that lowers the threshold for contact (94, 136).  
In Norway, access to care due to distance might be a problem as DFU multidisciplinary 
teams are not available at all hospitals. To further develop cooperation between 
specialist health care and the GPs, the use of a virtual outpatient clinic might facilitate 
supervision or guidance from specialist health care to promote early assessments and 
more integrated care. To this end, health care services in the UK have reported good 
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results (137-139). However, to facilitate such a service, there is a need for both 
technically safe equipment and organisational facilitation. Nevertheless, Norway has 
the technical potential and geographical needs to warrant the fostering of such national 
services.  
Patient awareness of foot ulcer behaviour is also important and must be strengthened. 
Specific patient education programs seem to be important and can improve patient 
knowledge and behaviour with respect to foot care, even though there is a lack of robust 
evidence that education alone can prevent reductions in ulcer and amputation incidence 
(140). Research has shown a positive relationship between regular foot inspections by 
health care professionals and regular self-inspections suggesting that health care 
professional behaviour during the clinical encounter with patients with diabetes may 
play an important role in increasing patient awareness of foot care (141, 142). To 
strengthen patient awareness, patient education on a public health level might help. For 
example, patient education through the social media, public and commercial TV 
channels and not only via health professionals might promote awareness about the 
importance of examining feet and making early contact with health care services even 
with minor problems.  
Severity of ulcers 
We found that ulcers classified at the highest and medium stage and grade were 
associated with increased healing time and that ulcers with the highest severity had an 
86% decreased rate of healing compared with low ulcer severity. In addition, patients 
with a combination of peripheral arterial disease, infection and ulcer-affected bones or 
joints were more likely to undergo amputations than ulcers with less severity. An 
association between severity of ulcer and amputation has been found in previous 
studies (13, 35, 57). These results indicate that early classification of patients with an 
ulcer is important. Grade and stage according to the UT classification system seem to 
be relevant predictors of healing time and amputation and thus act as a useful 
classification tool for clinicians in assessing the severity of the ulcers and initiating 
adequate treatment. Such a system may facilitate collaboration between the patient and 
the health care professional in improving outcomes and increasing patient awareness 
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of self-foot care. The classification system can be an important tool for the GP to 
describe the ulcer and assess the outcomes and can be used to increase the referral 
process between the two health care levels (143). In addition, the UT classification 
system could be supplemented with the use of 10-g monofilament to identify patients 
at risk of ulceration, since neuropathy is not part of the classification (33). 
6.2.2 Sample characteristics in study I and II 
Study I recruited patients from two out of the three hospitals included in Study II, but 
at different time periods. It may therefore have been of interest to see if there was a 
change in the quality of care with regard to characteristics and severity of ulcer. 
Baseline characteristics from Studies I and II showed that characteristics such as age, 
gender, type of diabetes, use of insulin, HbA1c, localization of ulcer and neuropathy in 
the two cohorts were markedly similar, except for cardiovascular disease. However, 
there was a higher prevalence of superficial ulcers in the RCT (Study II, 2012-2016) 
than in the retrospective cohort study (Study I, 2009-2011). In Study I, 22.9% of the 
ulcers were Grade 3 and 15.2% Grade 1, compared with 6.7% Grade 3 and 68.6% 
Grade 1 in Study II, respectively. Table 3 and 4, point 5.1 and table 5 and 6 point 5.2.  
A larger proportion of cardiovascular diseases was reported in Study I compared with 
Study II. One study has shown that macrovascular complications of diabetes is 
significantly related to a history of foot ulcer (46) and that they may reflect disease 
severity which can be one factor that may explain the differences in severity of ulcers 
between these two cohorts (46).  
Another explanation of the differences in severity of ulcers in the two samples can be 
that there has been substantial work in public health care in Norway to improve the 
quality of diabetes care (59, 144, 145). This has been related to targets being set for 
HbA1c at ≤ 8, stricter prevention of cardiovascular diseases among people with diabetes 
(144, 146), as well as a focus on prevention and early referral to specialist health care 
for treatment and follow up (59, 145). This has led to substantial improvement in health 
outcomes such as HbA1c, systolic blood pressure and cholesterol, indicating that the 
GPs are responding to these guidelines regarding risk factors (144). However, it is 
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unclear whether this has affected the difference in severity of diabetic foot ulcers in 
Norway since both cohorts have been influenced by these guidelines and the HbA1c in 
both groups was < 8. A more likely explanation might be the different inclusion criteria. 
In Study II, patients were excluded if they had a diagnosis of mental disorders or 
cognitive impairment (including schizophrenia, other psychotic disorders, and 
dementia), if they were unable to complete questionnaires in Norwegian, or if they had 
a life expectancy of less than one year. Mental disorders such as depression among 
patients with diabetes is associated with DFU and mortality and cohort studies of 
patients with DFUs have shown that depression is associated with more severe and 
larger foot ulcers at presentation (116, 147). It is therefore likely that exclusion of these 
patients has contributed to the high prevalence of superficial ulcers in Study II.  
6.2.3 Telemedicine follow-up 
The DiaFOTo project has, in addition to the studies included in this PhD thesis, 
published other studies contributing to the evidence base of telemedicine follow up for 
patients with DFUs (26, 113, 136, 148). In addition, some international studies have 
been published (94, 95, 103, 108, 109, 149, 150). The overall question is whether 
telemedicine follow up can be an alternative care pathway for patients with DFUs. To 
answer this question, I will discuss some prerequisites for implementation of 
telemedicine follow-up care of DFU such as clinical outcomes (healing, amputation 
and mortality), consultations and patient perspectives. 
Clinical outcomes (healing, amputation and mortality) 
Results from our study demonstrated that telemedicine was non-inferior to standard 
outpatient care in terms of healing time. Competing risk analyses showed no statistical 
differences in healing time between the two groups. Of the 182 patients, 78.9% 
experienced complete healing and there were no differences between the groups. The 
Danish study, which was comparable to our study due to the use of an asynchronous 
intervention and an RCT, found that telemedicine was not superior to standard 
outpatient care with respect to healing time (95). No statistical differences in healing 
time were found between the telemedicine and standard outpatient care groups and a 
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similar percentage healed in both studies (95). With respect to amputation, significantly 
fewer amputations occurred in the telemedicine group compared with the standard 
outpatient group in our study. This was in contrast to the Danish study where there 
were no significant differences between the two groups. These findings seem 
promising for telemedicine follow up. 
However, a higher mortality rate in the telemedicine group compared with the control 
group was reported in a Danish study (95). This is in contrast to our study where no 
significant differences in mortality between the two groups were found, but it is 
questioned whether telemedicine is relevant for all patients with DFUs. Our study 
excluded patients with mental disorders and life expectation less than 1 year. No such 
limitation was reported in the Danish study (95). In addition, the population recruited 
in our study had a very high prevalence of superficial ulcers (Grade 1) that may explain 
that we found no difference in mortality rate between the two groups in our study. 
Classification of the ulcers was not reported in the Danish study (95).  
It may be advisable to have a person-centred approach that individualises the treatment 
and not apply TM follow up initially to patients with complex and serious 
complications, but allow decisions to take place on a continuous basis. Our results from 
study II seems promising but the conclusions are most relevant for patients with more 
superficial ulcers. For some of these patients, telemedicine follow up may be relevant 
in phases where the wound healing is in progress. For many patients, such an approach 
may be appropriate, because the health condition or long travel time make it difficult 
to meet at the outpatient clinic (109, 151, 152). Such a decision should, however, be 
taken in close connection with the patient or the patient’s relatives if necessary. Still, 
several patients with severe and complex conditions preferred consultations to occur at 
the hospital rather than via telemedicine follow up. However, further studies are needed 
to investigate which other groups can benefit most from a telemedicine follow up. 
Outpatient consultations  
An important assumption for telemedicine’s success is that the number of consultations 
at the outpatient clinic would be reduced. Even though the study was not powered to 
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show differences in consultations between the two groups, it was unexpected that we 
did not find larger differences in the number of consultations between the telemedicine 
and standard outpatient groups. It may then be a possibility that the overall frequency 
of follow up in the outpatient clinic for the telemedicine group has affected the primary 
outcome. Similar findings have been reported in a qualitative study from Denmark 
where the staff did not find a decrease in the number of consultations in the outpatient 
clinic (94). On average, in our study, the telemedicine group had consultations every 
second week compared with the scheduled consultation every 6th week. The higher 
number of consultations in the telemedicine group was not explained by severity of 
ulcers in our study; that more severe ulcers need more frequent consultations at the 
outpatient clinic. Lack of strong leadership is also a factor that can hinder uptake of 
technology (148, 153, 154), but results from a supplementary article related to this RCT 
indicated that this was not a plausible explanation at the outpatient clinic (148). It is 
more likely that the experts at the outpatient clinic might not have had enough clinical 
experience with the telemedicine equipment, or that the community nurses requested 
frequent outpatient consultations due to lack of confidence in wound care or that the 
expert team at the outpatient clinic did not trust the competence of the community 
nurses. This is supported by patients’ experiences in Study III, where several patients 
expressed lack of competence and continuity of care among nurses in community 
health care as well as their failure to take any images of the ulcer. Similar findings 
related to lack of competence and continuity of care among nurses in community health 
care have been reported in previous studies (92, 155). However, only two out of three 
clinics were involved in the supplementary studies, and therefore, this conclusion may 
not apply to the clinic that attended the trial in 2015. Nevertheless, there is a potential 
for reducing the number of consultations using telemedicine.  
Diffusion of telemedicine solutions requires redesign of the health care service and new 
ways of cooperating between the two health care levels that need to be learned and 
accepted (156, 157). The subgroup analysis showed a reduced number of consultations 
in the outpatient clinic with the most experience. This seems logical, because experts 
at the outpatient clinic might be more confident collaborating with community nurses, 
more experienced with the telemedicine tool, and more convinced that treatment and 
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follow up works well between the two health care levels. The analysis also showed that 
within the telemedicine group, patients who lived more than 25 km from the outpatient 
clinics had significantly fewer consultations per month compared with patients who 
lived closer to the outpatient clinics. This was not the case for patients receiving 
standard outpatient care. Successful adoption of new technology is dependent on the 
technology being user-friendly and easy to learn (76, 148), on the health care 
professionals seeing advantages with its use (76, 148) and on the opportunity to discuss 
the expectations and usefulness of the telemedicine tool (77). To address these issues, 
risk analysis of the telemedicine intervention has been performed continuously during 
the process to improve the quality of the intervention (158). Further, the main strength 
with the telemedicine intervention used in our study was use of images supplemented 
with text, and the direct communication and collaboration between the two health care 
levels. This may have strengthened the clinical proximity and confidence between the 
expert nurses and community nurses, thus resulting in less need for frequent 
consultations at the outpatient clinic. Several studies have found that using digital 
images is helpful in clinical assessment to help nurses avoid over- and under-treating 
patients with wounds (159-161).  
Patients’ experience of follow up 
A reduction in the number of consultations at the outpatient clinic should not be seen 
in isolation, but also, seen in the context of the patient's experiences and needs. This 
relationship was not directly measured, but the patients in both groups emphasised in 
the interviews (152) that factors such as competence and continuity of care among 
community nurses in primary health care was of great importance (Study III). As long 
as these two factors were present, follow up in primary health care seemed to be an 
excellent care pathway. An absence of these factors led to a lack of confidence in 
wound care management and treatment, with the result that follow up at the outpatient 
clinic was then preferred. However, telemedicine seemed to counteract some of these 
challenges if telemedicine was used as intended. The patients in Study III claimed that 
the use of images and text together with continuous feedback and communication 
between the two health care levels seemed to be the factors that improved the 
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knowledge and skills of the community nurses. Similar findings among health care 
professionals have been previously reported in research (94, 109, 162) and recently in 
a supplementary article conducted during this trial about health care professionals’ 
experience with using telemedicine follow up (136). Telemedicine seems to be a unique 
arena that can promote professional discussions and reflections on clinical issues 
among health care professionals (136). This is opposite to standard outpatient care 
where the community nurses operate mostly alone and no formal cooperation between 
the two health care levels are usual. Another advantage with use of telemedicine is that 
telemedicine also appears to counteract some of the uncertainty the patients in study 
III experienced in the absence of continuity of care. Telemedicine can rapidly exchange 
information between the community nurses and expert nurses independent of which 
community nurse follows up the patient and thus promote continuity of care. From a 
management perspective this is valuable, because continuity of care can be difficult to 
establish due to shift schedules. However, the findings from study III indicated that use 
of telemedicine could be questionable in a number of circumstances. Some of the 
patients in Study III reported that the community nurses failed to take any images, and 
some nurses lacked the skills necessary to use the telemedicine devices. Similar issues 
have been reported in previous studies (94, 163). In addition, clear wound guidelines 
as well as clear guidelines for delegation of responsibility in the case of sickness and 
vacation among key staff are essential elements for success. All these issues need to be 
addressed before telemedicine can be successfully implemented in usual care (148, 
152). 
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 Conclusions and clinical implications   
 Duration of diabetic foot ulcer before start of treatment in specialist health care 
was an important predictor for ulcer healing. It is therefore necessary that people 
with diabetes and health care professionals are aware of the benefit of early contact 
with the health care system if foot ulcers occur. 
 
 The UT classification system seems to be an adequate tool to assess severity of 
ulcers and to predict outcomes such as healing time and amputation. The 
classification system can be an important tool for the GP to describe the ulcer and 
assess the outcomes used in the referral process and can be used to improve the 
referral process between the two health care levels. 
 
 Telemedicine has proven to be non-inferior compared to standard outpatient care 
in terms of time to healing. Further, there were no differences regarding mortality 
and patient satisfaction as well as fewer amputations in the telemedicine group, the 
findings suggest that telemedicine follow up can be an alternative and/or 
supplement to usual care. However, the conclusion seems to be most relevant for 
patients with more superficial ulcers due to the low proportion of ulcers of severe 
grade and stage and for patients with long distance from specialist health care. 
Telemedicine can thus reduce the burden long travel time and distance entails and 
reduce the pressure in the specialist health care.  
 
 An effective care pathway for patients with DFUs was dependent on a combination 
of competence and professional skills in wound care management and continuity 
of care. The combination of these two factors did not only promote a more 
integrated care pathway, but also increased patient’s confidence. Telemedicine can 
promote both professional’s competence and continuity of care, but depends on 




 We did not find fewer consultations in the telemedicine group compared with the 
standard outpatient care group, but found that number of consultations were lower 
when health care providers gained more experience using the telemedicine 
equipment. Adoption of new technology in diabetes foot care involves health care 
providers working across different levels with different organisational systems and 
cultures. Therefore, user-friendly technology, ongoing training in how to use the 
technology and clear distribution of responsibilities are needed for successful 
adoption of the technology (76, 148). Further, as of today, there is no financial 
incentive or diagnosis-related groups (DRG) reimbursement for asynchronous 
systems in relation to telemedicine consultations or systematic work conditions that 
are intended for use of such a service. This means in practice that health care 
professionals must perform telemedicine tasks in addition to their normal tasks 
(72). Further, the web-based ulcer record system used in Study II is not integrated 
into the internal hospital or community electronic medical records of collaborating 
partners due to legal aspects (113). Lack of a shared medical record system makes 
the documentation overly complicated and the collaboration challenging (113). 
This may indicate that if telemedicine is to be implemented more as a service, these 
issues need to be solved. 
 
 Use of technological solutions open up new ways to communicate and collaborate 
between primary and specialist health care and support integrated care for patients 
with DFUs. To further develop cooperation between specialist health care and GPs, 
the use of a virtual outpatient clinic might facilitate supervision or guidance from 
specialist health care to promote early assessments and more integrated care (164). 
Another solution is to replace the mobile phone with a tablet computer that allows 
virtual access to the web-based ulcer record in order to facilitate an improved 
workflow for the health care professionals (148).  
63 
 Further Research  
This study has identified some further questions and need for further research. 
Early contact with the health care system if an ulcer occur: We found a positive 
association between duration of ulcer and healing time, but we do not know how long 
patients waited before contacting the GP, nor do we know how long the GP treated the 
ulcer before referral to the specialist health care. Such information could be valuable 
regarding causes for the delayed referral to specialist health care and these issues can 
successfully be explored by a qualitative approach. 
 
Telemedicine follow up: Results from the RCT in the present study generate research 
questions such as which groups of patients with DFUs that could benefit most from 
telemedicine follow up. In addition, different telemedicine solutions should be 
investigated in further collaboration between health care levels and between health care 
providers and patients. 
 
Telemedicine follow up and cost-effectiveness: The impact of costs-effectiveness of 
telemedicine follow up is of importance to inform policy decisions. Focus on cost-
effectiveness of telemedicine follow up compared with standard outpatient care of 
patients with DFUs should be encourage as there is limited research on these issues. 
 
Patient experience: The findings from study III indicated that the patient’s experiences 
are valuable in the decision of implementation of telemedicine follow up. Further 
research should focus on patients reported outcomes (quality of life) when new 
technology is applied. 
 
Telemedicine across countries: Few studies have been performed regarding 
telemedicine follow up among patients with DFU worldwide. Therefore, it would be 
of interest at an international level to perform multicenter prospective across-countries 
research of telemedicine follow up among patients with DFUs. 
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Competence among health care professionals and continuity of care: Findings from 
study III indicate that these issues were of importance in follow up of patients with 
DFUs. Further research should be directed to explore whether health care personnel 
increase their competencies as a result of telemedicine use and if this contributes to a 
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To investigate whether A) duration of ulcer before start of treatment in specialist health care,
and B) severity of ulcer according to University of Texas classification system (UT) at start
of treatment (baseline), are independent predictors of healing time.
Methods
This retrospective cohort study, based on electronic medical record data, included 105
patients from two outpatient clinics in Western Norway with a new diabetic foot ulcer during
2009–2011. The associations of duration of ulcer and ulcer severity with healing time were
assessed using cumulative incidence curves and subdistribution hazard ratio estimated
using competing risk regression with adjustment for potential confounders.
Results
Of the 105 participants, 45.7% achieved ulcer healing, 36.2% underwent amputations, 9.5%
died before ulcer healing and 8.5% were lost to follow-up. Patients who were referred to spe-
cialist health care by a general practitioner 52 days after ulcer onset had a 58% (SHR
0.42, CI 0.18–0.98) decreased healing rate compared to patients who were referred earlier,
in the adjusted model. High severity (grade 2/3, stage C/D) according to the UT classifica-
tion system was associated with a decreased healing rate compared to low severity
(grade1, stage A/B or grade 2, stage A) with SHR (95% CI) equal to 0.14 (0.05–0.43) after
adjustment for referral time and other potential confounders.
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Conclusion
Early detection and referral by both the patient and general practitioner are crucial for opti-
mal foot ulcer healing. Ulcer grade and severity are also important predictors for healing
time, and early screening to assess the severity and initiation of prompt treatment is
important.
Introduction
Diabetic foot ulcer is a feared complication of diabetes with a yearly incidence around 2–4%
[1]. A diabetic foot ulcer has a variety of causes, often including peripheral ischemia, neuropa-
thy or both. Ulcer healing takes weeks or months, and one-third of ulcers never heal with
amputation as the consequence [2].
Factors affecting healing time include duration of ulcer, but limited research on the influ-
ence of duration of ulcer before treatment starts in specialist health care is available. Although
some have investigated the associations between duration of ulcer before specialist health care
treatment and healing time among persons with a diabetic foot ulcer [3–7], referral pathways
are still not optimal. Many patients have delayed specialist health care referral due to lack of
awareness of the potential consequences of a diabetic foot ulcer among patients and health
care professionals and poor management strategies or ischemia detection [8]. In Norway, gen-
eral practitioners coordinate medical follow-up and serve as “gate keepers” to specialist care,
but still there are unclear referral practices between primary and specialist health care [9]. The
importance of optimal referral patterns is also emphasised in international guidelines [10, 11].
However, to our knowledge, no studies have assessed the different periods of the referral path-
way among individuals with diabetic foot ulcers. More evidence is therefore needed to assess
the delay in referral pathways and the impact of these delays.
Diabetic foot ulcer treatment is challenging and time-consuming. Thus, predicting out-
comes among patients with diabetic foot ulcers help clinicians to provide effective manage-
ment strategies [12]. Using screening tools to identify vulnerable subgroups to detect diabetic
foot ulcers at an early stage is important. However, the use of classification systems as a screen-
ing tool in clinical practice is scarce [13]. The University of Texas (UT) classification system is
one of few systems that have been validated [13–15]. Although widely used, it is emphasised
that more research is needed to assess to what degree this system reflects the population for
which it is intended [16]. In Norway, a diabetic foot risk classification system has not yet been
implemented in national guidelines. Thus, the UT classification system might be relevant for
investigating predictors for healing time.
By utilizing a Norwegian cohort of foot ulcer patients from specialist health care outpatient
clinics our main aim was to investigate the association of the following time fractions with
healing time: the total duration of ulcer before start of treatment in specialist health care,
defined as the time from patient-reported ulcer onset to start of treatment in specialist health
care and two different fractions of duration of ulcer: 1) time from patient-reported ulcer
onset to referral by general practitioner to specialist health care and 2) time from referral by
general practitioner to start of treatment in specialist health care. In addition, we wanted to
explore whether severity of the ulcer in terms of grade and stage at start of treatment in special-
ist health care was associated with healing time and whether duration of ulcer and severity
showed independent associations after mutual adjustment and adjustment for other potential
confounders.
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Abbreviations: UT classification system, University
of Texas classification system; PAD, peripheral
arterial disease; SHR, subdistribution hazard ratio;
GP, General practitioner; SHC, specialist health
care.
Material and methods
This retrospective cohort study included all patients with a new diabetic foot ulcer presenting
for the first time at two specialist outpatient clinics in Western Norway between 1 January
2009 and 31 December 2011 (Fig 1). In this study period, guidelines for foot assessment and
treatment were provided through the National Professional Guideline for Diabetes—preven-
tion, diagnosis and treatment (IS-1674) [17].
Patients previously treated for foot ulcers in specialist health care in the last 12 months
before baseline were excluded. Each patient was followed to healing, amputation or death. A
foot ulcer was defined as a skin lesion below the ankle. Participant information relating to
baseline and follow up was obtained from medical electronic records. We recorded data on a
standardised record form designed for this study and based on the research literature, clinical
guidelines and expert opinions. A nurse specialized in diabetes and wound treatment from
each outpatient clinic collected data from medical records. Data were collected between Febru-
ary 8, 2015 and January 2, 2016.
Missing values for the different variables are reported in Table 1. In the competing risk
analysis missing data were addressed by listwise deletion. Overall, most of the information
required was available, except for information on ulcer area. 41.9% of the patients did not have
this information on ulcer area, thus, we decided not to include ulcer area as a study variable.
Main exposures
The main exposure variables were duration of ulcer and ulcer severity. Duration of ulcer was
defined as the time from patient-reported ulcer onset to start of treatment in specialist health-
care using the tertiles: 0–27 days, 28–59 days and 60 days and further divided into two peri-
ods: 1) time from patient-reported ulcer onset to referral by general practitioner to specialist
health care (divided into three groups using the tertiles: 0–13 days, 14–51 days and 52 days)
Fig 1. Flowchart: Study population.
https://doi.org/10.1371/journal.pone.0177176.g001
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and 2) time from referral by general practitioner to start of treatment in specialist health care
(divided into three groups using the tertiles: 0 days, 1–13 days and 14 days). There are no
established cut-off criteria for defining short, medium and long referral time; therefore, we
chose to use tertiles to avoid biased cut-offs.
Ulcer severity was classified according to the UT classification system [15, 18] as grade 1
(superficial wound not involving tendon, capsule or bone), grade 2 (penetrating to the tendon
or capsule) or grade 3 (penetrating to the bone or joint). Patients with ulcer grade 0 (com-
pletely healed ulcer) were excluded. Stages were: clean wounds (stage A); non-ischemia, in-
fected (stage B); ischemia, non-infected (stage C); or ischemia, infected (stage D). Because of
the small numbers in some categories, we combined grade and stage into three categories
defined as low severity, medium severity and high severity determined from a clinical perspec-
tive. Low severity was defined as Grade 1 + stage A/B or grade 2 + stage A. Medium severity
was defined as: Grade 1 + stage C/D or grade 2 + stage B or grade 3 + stage A/B and high sever-
ity was defined as grade 2/3 combined with stage C/D.
If the patient had multiple ulcers, the most severe ulcer (according to UT classification sys-
tem), was selected as the index ulcer. This selection was made before collecting data on
whether the ulcer healed.
Demographic and clinical variables
Demographic and clinical variables which were considered to be potential confounders were
sex, age, HbA1c, coronary disease, vascular surgical treatment, and neuropathy. These vari-
ables were selected based on previous literature and clinical judgement. Age was defined as the
age at first consultation at the outpatient clinic. HbA1c measurements were reported in the
International Federation of Clinical Chemistry units (mmol/mol) in addition to derived NGSP
units (%) upon attendance at the outpatient clinic. Coronary disease was defined as having
angina pectoris, history of myocardial infarction, previous coronary angioplasty or artery cor-
onary bypass operation. Vascular surgical treatment includes information on percutaneous
transluminal angiography of the peripheral arteries or bypass. Neuropathy was defined as an
abnormal pressure sensation evaluated with the 10-g monofilament [19].
Outcome, competing events and follow-up time
The outcome was healing time, defined as the time from the start of treatment in specialist
health care until ulcer healing. Healing was defined as healing (intact skin) of the whole foot
without any surgery in the period of study. Amputation and death were considered competing
events. Follow-up time was calculated as time from the date of inclusion (= treatment start in
specialist health care) until healing, amputation, death or loss to follow-up, whichever came
first. Amputation performed below the ankle was defined as minor amputation, whereas
amputation above the ankle was defined as major amputation [20].
Statistical analysis
Descriptive statistics for the study population at baseline were calculated as mean, standard
deviations, counts and percentages. Tests for associations between categories of referral time
and categories of ulcer severity were conducted using chi-square tests. Cumulative incidence
functions for healing time were calculated using the stcompet command in Stata, with amputa-
tion and death treated as competing events. Cumulative incidence functions were calculated
separately for duration of ulcer divided into two periods, and for the three combinations of
grade and stage. Fine & Gray competing risk regression analysis [21] were used to calculate the
association of duration of ulcer, ulcer severity classified according to the UT classification
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system and healing time, and association between amputation and ulcer severity. Amputation
and death were treated as competing events in the subdistribution hazard regression model
while loss to follow up were treated as censored observations [22]. Results were reported as sub
distribution hazard ratio (SHR) with 95% confidence intervals.
We investigated the associations of predictors, potential confounders and the outcome
using univariate competing risk regression models (model 1). Then, we constructed a model
where the main exposures, the two factions of duration of ulcer and ulcer severity, were mutu-
ally adjusted (model 2). Finally, we constructed a multivariate competing risk regression
model including potential confounders, such as age, sex, HbA1c, coronary disease, vascular
surgical treatment and neuropathy, in addition to the two fractions of ulcer duration and ulcer
severity (model 3). Potential deviations from the proportional hazards assumption were inves-
tigated by including covariates as time-dependent covariates in the model. No significant
time-dependent effects were found.
Statistical significance was defined as P< 0.05 in all analyses. SPSS version 22 was used for
the description of baseline data, and Stata version 14 was used for competing risk regression
and to construct cumulative incidence function curves in competing risk analyses.
Ethics
The study was approved by the Western Norway Regional Committee for Medical and Health
Research Ethics (2011/1609). Study information was sent to all participants still alive at regis-
tration, and informed consent was obtained.
Results
Subjects characteristics
In total, 151 participants with a diabetic foot ulcer were identified from 2009–2011, and 46
patients were excluded because they did not meet the inclusion criteria; ulcer healed at first
consultations at the specialist health care clinic, (n = 6), no need for further follow-up in spe-
cialist health care at first consultation in specialist health care (n = 6), declining to participate
(n = 29) and unknown address (n = 5). Thus, the study sample comprised 105 patients (Fig 1).
The clinical characteristics of the patients are reported in Table 1. The average age among the
patients was 68.7 years (SD ±14.8), 70.5% were men, 79% had type 2 diabetes with a mean
HbA1c 7.9% (SD ±1.6). Coronary disease and neuropathy were present in 45.7% and 65.7% of
patients respectively, and 38.1% had an ulcer duration of 60 days or more before the start of
the treatment at the specialist outpatient clinic (Table 1).
The association between the three-category ulcer severity variable and time from patient-
reported ulcer onset to referral by general practitioner to specialist health care is shown in
Table 2. The association was significant (P = 0.042) with a higher proportion with short dura-
tion time from ulcer onset until referral among those with less severe ulcers (50%), compared
to those with more severe ulcers (34.9%). Fifty percent of patients with low ulcer severity had
ulcer duration of 0–13 days before referral to specialist health care, while only 16% of patients
with high severity had 0–13 days duration before referral. In the group with high severity,
34.9% of the patients had waited 52 days or more before referral. Corresponding tests for the
other two referral time variables showed no significant associations with ulcer severity.
Main exposures
Thirty-eight point one percent of patients had had an ulcer 60 days or more before the start of
treatment in specialist health care, 31.4% of patients had had an ulcer for 52 days from
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patient-reported ulcer onset to referral by general practitioner to specialist health care, whereas
34.3% waited more than 14 days from referral by general practitioner to treatment start in spe-
cialist health care (Table 1).
Ulcer characteristics of patients with a diabetic foot ulcer according to UT classification
system at baseline is presented in Table 3. Peripheral arterial disease, infection and ulcer pene-
trating to bone or joint were present in 24 (22.9%) patients (grade 3/stage D), of these, 20
underwent amputation (10 minor amputations, 10 major), 2 experienced complete ulcer heal-
ing and 2 died before the ulcer healed. No patients with grade 1, stage A underwent amputa-
tion (Table 3). The categorization of patients into low-medium and high severity is shown
with shadings in the table.







Age, years, mean, (SD) 68.7
(14.8)
Disease-related variables
Diabetes type n (%)
Type II 83 (79.0)
Insulin treatment, n (%)
Did use insulin 68 (64.8)
HbA1c (mmol/l), Mean (±SD) 63 (±17.5)
HbA1c (%), Mean (±SD) 7.9 (±1.6)
Coronary diseases, n (%) 48 (45.7)
Neuropathy, n (%) 69 (65.7)
Ulcer variables
Time from patient-reported ulcer onset to start of treatment in specialist health care, n (%)
0–27 days 33 (31.4)
28–59 days 28 (26.7)
 60 days 40 (38.1)
Missing 4 (3.8)
Time from patient-reported ulcer onset to referral by general practitioner to specialist health
care, n (%)
0–13 days 26 (24.8)
14–51 days 40 (38.1)
 52 days 33 (31.4)
Missing 6 (5.7)
Time from referral by general practitioner to start of treatment in specialist health care, n (%)
0 days 26 (24.8)
1–13 days 41 (39.1)
 14 days 36 (34.3)
Missing 2 (1.9)





Percutaneous transluminal angiography /Bypass 26 (24.8)
https://doi.org/10.1371/journal.pone.0177176.t001
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Outcome
In total, 48 (45.7%) patients’ ulcers healed completely without preceding amputation (either
major or minor) and 38 (36.2%) underwent amputation (24 minor amputations and 14 major
amputation). Ten (9.5%) patients died before the ulcer healed and nine (8.5%) patients were
lost to follow-up. The median follow-up time measured from start of treatment in specialist
health care to end of follow-up was 67 days (SD ± 185.4) for the total sample (including those
who healed, amputated, died and lost to follow up). Mean follow-up time was 130 days. The
median time measured from start of treatment in specialist health care to ulcer healing, includ-
ing only those who healed, was 75.5 days (SD 123.4). Mean healing time was 113 days.
Cumulative incidence curve. Cumulative incidence curves of healing time stratified by
duration of ulcer are shown in Fig 2. Patients in the upper tertile of time from ulcer onset to
referral by general practitioner to specialist health care ( 52 days after ulcer onset) had
increased healing time compared to earlier referral. There was no significant difference
between the tertiles of time from referral by general practitioners to start of treatment in spe-
cialist health care.
Cumulative incidence curves of healing time stratified by severity of ulcer (levels of grade
and stage), are seen in Fig 3, which shows an increased healing time for patients with a high
severity of ulcer compared to the two other categories of grades and stages.
Univariate competing risk regression analysis. The total duration of the ulcer from ulcer
onset to start of treatment in specialist health care showed no significant association with heal-
ing time (SHR 0.62, CI 0.30–1.28). When duration of ulcer was divided into two periods, there
was no association with time from general practitioners’ referral to specialist health care to
Table 2. Association between severity of ulcer according to the UT classification system and time from patient-reported ulcer onset to referral by
general practitioner to specialist health care.
Time from PRUO1 to referral by GP2 to SHC3 Low severity Medium severity High severity Total p
0–13 days 12 (50.0) 7(21.9) 7 (16.3) 26 (26.3) 0.042
14–51 days 6 (25.0) 13 (40.6) 21 (48.8) 40 (40.4)
 52 days 6 (25.0) 12 (37.5) 15 (34.9) 33 (33.3)
Total 24 (100) 32 (100) 43 (100) 99(100)
1PRUO = patient reported onset of ulcer
2GP = General practitioner
3SHC = Specialist health care
https://doi.org/10.1371/journal.pone.0177176.t002
Table 3. Ulcer characteristics of patients with a diabetic foot ulcer according to UT classification system at baseline.
Stage Grade 1 Grade 2 Grade 3 Total
A Clean wound 16 (15.2) 1(1.0) 1 (1.0) 18 (17.1)
B PAD -, infection + 8 (7.6) 10 (9.5) 11 (10.5) 29 (27.6)
C PAD +, infection - 8 (7.6) 5 (4.8) 6 (5.7) 19 (18.1)
D PAD +, infection + 5 (4.8) 10 (9.5) 24 (22.9) 39 (37.1)
Total, n, (%) 37 (35.2) 26 (24.8) 42 (40.0) 105 (100)
PAD: Peripheral arterial disease.
Grade 0: Pre-or post-ulcerative lesion, Grade 1: Superficial wound, not involving tendon, capsule or bone, Grade 2: Wound penetrating to tendon or
capsule, Grade 3: Wound penetrating to bone or joint.
White area: low severity, Light Grey area: medium severity, Dark grey area: high severity.
https://doi.org/10.1371/journal.pone.0177176.t003
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start of treatment and healing time, but there was a strong association between the time from
patient-reported ulcer onset to referral by general practitioner to specialist health care with
healing time. Patients who were referred to specialist health care by a general practitioner 52
days or more after the onset of ulcer had a 67% (SHR 0.33, CI 0.15–0.72) decreased rate of
healing compared to those referred earlier. Older age and vascular surgical treatment were also
associated with a decreased rate of healing time (Table 4, model 1).
High ulcer severity ulcer had 87% (SHR 0.13, CI 0.06–0.28) decreased rate of healing com-
pared to low severity. Ulcer of medium severity had 55% decreased rate of healing compared
to ulcer with low severity (SHR 0.45, CI 0.24–0.85) (Table 4, model 1). Competing risk analyses
with amputation as the endpoint showed a significant association for ulcer severity with three
times higher risk of amputation in the category with high severity compared to the category
with low severity (SHR 3.15, CI 1.49–6.66) (results not shown in tables). We did not observe
any significant associations between total duration of ulcer and risk of amputation or between
time from patient-reported ulcer onset to referral by general practitioner to specialist health
care and risk of amputation (results not shown in tables). We did however observe a significant
association between time from general practitioners’ referral to specialist health care to start of
treatment and risk of amputation with a lower risk of amputation among those who waited
more than 14 days compared to those who had their first appointment the same day as they
were referred (SHR 0.41, CI 0.18–0.94). Among the 26 patients having their first appointment
the same day as they were referred, 54% ended up with a minor or major amputation.
Multivariate analysis. Estimated SHRs increased slightly for patients who had an
ulcer 52 days from 0.33 to 0.38 when the following variables were included in the same
model: time from patient-reported ulcer onset to referral by general practitioner to specialist
Fig 2. Cumulative incidence curves of healing time stratified by duration of ulcer. P-values from univariate competing risk regression.
https://doi.org/10.1371/journal.pone.0177176.g002
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health care, time from referral from general practitioner referral to start treatment in specialist
health care and ulcer severity (Table 4, model 2). When age, sex, HbA1c, coronary disease, vas-
cular surgical treatment and neuropathy were entered into the model, the SHRs for time from
patient-reported ulcer onset to referral by general practitioner to specialist health care, time
from referral from general practitioner to start of treatment in specialist health care and ulcer
severity did not change markedly. Age and vascular surgical treatment were associated with
reduced healing time in the univariate analysis, but the association did not remain significant
after adjustment in the multivariate analysis (Table 4, model 3). For ulcer severity, the associa-
tion was still significant after adjustment for both duration of ulcer and potential confounders.
The significant association between time from referral from general practitioner to start of
treatment in specialist health care and risk of amputation observed in the univariate competing
risk model was no longer significant after adjustment for severity of the ulcer.
Discussion
Time from patient-reported ulcer onset to referral by general practitioner to specialist health
care and the two highest levels of ulcer severity were independently associated with healing
time for diabetic foot ulcer while controlling for age, sex, HbA1c, coronary disease, vascular
surgery treatment and neuropathy.
The results show that duration of ulcer before starting specialist health care treatment influ-
enced healing time, with time from onset of ulcer to referral by the general practitioner as the
main contributor to the association. The waiting time between referral and start of treatment
in specialist health care did not show a significant association with healing time and SHR’s
Fig 3. Cumulative incidence curves of healing time stratified by severity of ulcer. P-values from univariate
competing risk regression.
https://doi.org/10.1371/journal.pone.0177176.g003
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were actually greater than 1. reflecting a tendency to higher probability of healing among those
who waited14 days for an appointment. This could possibly partly be explained by the
observed inverse association between waiting time and risk of amputation, with significantly
higher risk of amputation among those who waited 0 days compared to those who waited14
days, leaving fewer patients behind to experience healing. Among the 26 patients who had
their first appointment in specialist health care the same day as the referral, 61.5% had a
wound in stage C or D and 54% ended in amputation, indicating very severe ulcers. The lack
of an association between total duration of ulcer and healing time could possibly also be
explained by the tendency to an association in the opposite direction for the second part of the
duration time.
Table 4. Subdistribution hazard regression model to calculate the association between duration of ulcer, severity of ulcer and healing time.
Total (n = 105) ulcer










Time from patient-reported ulcer onset to start of
treatment in specialist health care
0–27 days 33/16 1
28–59 days 28/18 1.58 (0.81–3.08)
 60 40/13 0.62 (0.30–1.28)
Time from patient-reported ulcer onset to referral
by general practitioner to specialist health care
0–13 days 26/17 1 1 1
14–51 days 40/19 0.57 (0.29–1.11) 1.00 (0.52–1.93) 1.16 (0.51–2.62)
 52 days 33/10 0.33 (0.15–0.72) 0.38 (0.17–0.86) 0.42 (0.18–0.98)
Time from referral by general practitioner to start of
treatment in specialist health care
0 days 26/11 1 1 1
1–13 days 41/20 1.33 (0.66–2.67) 1.45 (0.68–3.09) 1.56 (0.62–3.90)
 14 days 36/16 1.30 (0.61–2.76) 1.76 (0.83–3.77) 1.84 (0.70–4.84)
Severity of ulcer classified after UT classification
system
Low severity 20/25 1 1 1
Medium severity 18/35 0.45 (0.24–0.85) 0.45 (0.23–0.91) 0.45 (0.23–0.88)
High severity 10/45 0.13 (0.06–0.28) 0.14 (0.06–0.30) 0.14 (0.05–0.43)
Age 105/48 0.98 (0.96–1.00) 1.00 (0.98–1.03)
Sex
Male 74/35 1 1
Female 31/13 0.85 (0.46–1.58) 0.66 (0.36–1.23)
HbA1c 105/48 0.98 (0.82–1.18) 1.12 (0.87–1.44)
Coronary disease
No 57/26 1 1
Yes 48/22 0.85 (0.49–1.48) 1.04 (0.55–1.96)
Vascular surgery treatment
Yes 26/5 0.24 (0.10–0.59) 0.59 (0.19–1.79)
No 79/43 1 1
Neuropathy
Yes 69/35 1.33 (0.70–2.51) 1.05 (0.53–2.07)
No 36/13 1 1
https://doi.org/10.1371/journal.pone.0177176.t004
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Margolis and colleagues (2002) [3] evaluated the association between different risk factors
and healing time among 31,106 participants with neuropathic foot ulcers. They found that
increased wound duration before initial treatment start in specialist health care was one of the
major factors associated with reduced healing. However, these results were not supported in a
UK study of 449 participants with diabetic foot ulcers [4]. These authors speculated whether
this was caused by the fact that the date of ulcer onset simply was recorded by month. In the
Eurodiale study, the variation between countries was considerable, with inconclusive results
concerning healing time [2, 23]. In a recent British report (2016), findings indicated that the
ulcer healing time increased compared to shorter interval if the interval to first assessment by
specialist was > 2 months after ulcer onset [7]. Although the number of patients in our study
was relatively small, we found that longer duration of ulcer before specialist health care treat-
ment was associated with decreased healing rate. Our results underscore that the interval from
patient-reported ulcer onset to specialist health care referral by a general practitioner seems
more important than the interval between referral and the start of specialist health care treat-
ment. In the Norwegian health care system, general practitioners are responsible for coordi-
nating medical follow-up [24]. However, we did not find that more superficial DFU took
longer for referral, but rather the opposite. Fifty percent of patients with low severity of the
ulcer had an ulcer duration of 0–13 days before referral to SHC while only 16% of patients
with high severity had 0–13 days duration before referral. In the group with high severity,
34.9% of the patients waited 52 days or more before referral. It is difficult to explain the rea-
sons for this finding. It might be that patients with more severe ulcers waited for a long time
before contacting the GP or that the GP tried to treat the ulcer before referring the patient to
the specialist health care. We lack information of both these aspects. However, the data give
valuable information of the importance of early referral to specialist health care to avoid
severe complications. Therefore, it is important to communicate to patients and health care
professionals in primary health care that referral pathways and adequate access to general
practitioner services are crucial. Reduced function and further adverse complications can be
prevented if ulcers are identified at an early stage [8, 10, 25]. A better follow-up strategy in
primary health care and models that facilitate communication across different care levels
should be considered.
Delayed specialist health care treatment start was seen in many patients, although guide-
lines stress the importance of early treatment to avoid adverse complications [10, 11]. In our
cohort, 38.1% of patients had a duration of ulcer 60 days (2 months) prior to the start of spe-
cialist health care treatment. This is comparable with the results of the Eurodiale study involv-
ing 14 countries, where over 27% of participants were treated for >3 months before initial
specialist health care treatment [8], while only 7.7% among patients with DFU in England and
Wales had more than 60 days (2 months) delayed referral time to specialist health services [7].
Although substantial differences among countries exist, current guidelines were not followed
when treating a significant number of patients [8, 11]. Our study showed a strong association
between delayed referral to a specialist unit and healing time after adjustment for potential
confounder with clear implications for routine care. Treatment is effective, guidelines are
available and early intervention seems to reduce the burden of an adverse outcome.
The present cohort has a higher incidence of amputation and relative low incidence of ulcer
healing compared to other studies [6, 8, 23]. In total, 52% of the ulcers leading to amputation
were affected by infection, peripheral artery disease and ulcers penetrating to bone and joint
These more severe risk factors may have had an impact on the relative high incidence of ampu-
tation. One other possible explanation might be that our definition of healing did not include
minor amputation, which is in contrast to some other studies [6, 26]. In these studies, minor
amputation could be regarded as a strategy leading to healing.
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Ulcers of the highest and medium stage and grade were strongly associated with decreased
rate of healing. Both peripheral arterial disease, independently and in combination with infec-
tion, are known predictors of ulcer healing leading to prolonged healing time. Patients with
the combination of PAD, infection and ulcer penetrating to bone or joint were also more likely
to undergo amputation than those with less severe ulcer stage [2, 23, 27]. In our cohort, PAD,
infection and ulcer penetrating to bone or joint with amputation as an endpoint were seen in
20 of the patients. Given the association between severity of ulcer and healing time, early
screening of people with a new ulcer is imperative to assess the severity and initiate adequate
treatment to reduce the risk of amputation [2, 27].
We found an association between severity of ulcer and duration of ulcer, but the duration
of ulcer and severity of ulcer still showed significant associations with healing time after
mutual adjustment and adjustment for potential confounders. First, the persistent associations
after adjustment for duration of ulcer indicate that ulcer severity at the first specialist health
care consultation was important for healing time, regardless of how long the ulcer had lasted
before the first consultation. In other words, an ulcer with a severe grade and severe stage has
an increased healing time, even if it did not last long before start of treatment. Second, the
independent association for duration of ulcer indicates that duration of ulcer affects healing
through mechanisms other than greater ulcer severity. Other possible factors might be the
quality of general practitioners’ treatment and a lack of health awareness among this patient
group.
There are several limitations in this retrospective cohort study. First, the sample size is rela-
tively small, which limit the statistical power. However, these results may still provide new
knowledge about independent predictors for healing time and implications for further
research. Second, in total 69.5% of the potential participants were included in the study. Non-
participants might have been in worse health status, and this could potentially lead to selection
bias. The increased healing time associated with duration of ulcer before start of treatment in
specialist health care and severity of ulcer in the present study might therefore have been
underestimated. Third, we acknowledge that the UT classification system omits reference to
ulcer area. In our study we were not able to examine the impact of ulcer areas on healing due
to missing data on ulcer size (cm2) (41.9%). In the time period that data were collected, it was
not common to use pictures to measure ulcer area, which may explain the high occurrence of
missing. As the UT classification system provides a standard description of an ulcer and help
predict outcomes we decided only to use the UT classification system in the analyses. Fourth,
the possible impact of early amputation as a strategy to obtain healing would be interesting to
investigate, but this was not possible since follow-up was terminated at the time of minor or
major amputation. Therefore, we do not know the healing time for patients who experienced
ulcer healing after a minor amputation. Fifth, the incidence of amputation was high in this
study, especially among those who had their first appointment in specialist health care the
same day as they were referred by the GP, causing a non-significant increased rate of healing
among those who waited longer for an appointment after referral was sent by the GP. In a pop-
ulation with a lower incidence of amputation, it might be more likely to observe an increased
rate of healing with shorter waiting time, but the strength of the association would be weak-
ened if patients with more severe ulcers have shorter waiting time. Sixth, information on how
long the patient waited before he/she contacted a general practitioner was unavailable for most
patients and could therefore not be included in the analysis. Finally, data on whether the gen-
eral practitioner had treated the ulcer before the patient was referred to specialist health care
was also lacking. Such information could provide important information on the causes of
delayed referral, and further studies are necessary to assess the importance of these factors.
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In summary, duration of diabetic foot ulcer before the start of treatment in specialist health
care and ulcer severity influenced healing time independently of each other. Early identifica-
tion of the ulcer by the patient and the general practitioner, as well as early referral by a general
practitioner to specialist health care are important for ulcer healing and have clear implications
for routine care. Grade and stage severity are important predictors for healing time. Early
screening might identify patients needing extra support in treatment and follow-up care.
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Introduction:  Diabetic  foot  ulcers  are  a feared  complication  of  diabetes.  Care  delivered  via  telemedicine
is  suggested  to  be  a  more  integrated  care  pathway  to  manage  diabetic  foot  ulcers  than  traditionally
delivered  healthcare.  Our  aim  was  to  explore  patients’  experiences  with  telemedicine  follow-up  care  as
compared  to  traditional  care.
Methods: Interpretive  description  was  used  as  an analysis  strategy.  Data  were  collected  using  individual
semi-structured  interviews  in  the  context  of  a  larger  ongoing  clustered  randomized  controlled  trial.
Twenty-four  patients  (13  in  the  intervention  group;  11 in  the  control  group),  aged  38–88  years  were
purposively  recruited  from  the  RCT  in order  to  obtain  a  diverse  sample  in  terms  of  group  composition
(intervention  vs.  control),  age,  gender,  marital  status,  setting,  and  comorbidities  present.  The  control
group  received  traditional  care.
Results: Three  themes  emerged  from  the  interpretive  analysis:  competence  of  healthcare  professionals,
continuity  of  care,  and  easy  access.  This  was  independed  of  types  of  follow-up  that  had  limited  impact  on
the  patients’  follow-up  experiences.  Competence  of  healthcare  professionals  and continuity  of  care  were
crucial,  because  they  can  either  enhance  or jeopardize  wound  care.  If  these  two  latter  factors  were  absent,
patients  would  lose  confidence  in  the wound  care  process.  If this  happened,  patients  pointed  out  that  the
expert  knowledge  of  a specialist  clinic  was  essential  to  receive  good  care.  When  telemedicine  functioned
optimally,  telemedicine  was  an  advantage  in  the  treatment,  because  the  images  quickly  captured  changes
in  the  wound  healing  that  immediately  could  be  corrected.  Easy  access  is  important  for  patients,  but  the
importance  of  accessibility  appears  to  be  primary  when  the  other  two  factors  were  present.
Conclusion: The  best  wound  care  pathway  for  patients  with  diabetes  foot  ulcers  is depended  on  a combina-
tion  of  competence  and  professional  skills  in  wound  management,  and  continuity  of  care.  If telemedicine
is  functioning  as intended,  it  can  be  an  important  additional  tool.
© 2016  Published  by  Elsevier  Ireland  Ltd.
1. Introduction
Diabetic foot ulcers severely affect patients’ quality of life [1].
They are worrisome complications of diabetes, as they can take
months to heal and can lead to osteomyelitis and amputation [2].
∗ Corresponding author at: Faculty of Health and Social Science, Centre for
Evidence-Based Practice, Bergen University College, Inndalsveien 28, Bergen, N-
5063, Norway.
E-mail address: hss@hib.no (H. Smith-Strøm).
In Norway, and in other countries, home care nurses in col-
laboration with the general practitioner (GP) have the primary
responsibility for treatment and follow- up of patients with ulcers
in  collaboration with the specialist health care service [3–5]. How-
ever, in the current system it is reported that the collaboration
between primary health care and specialist health service is not
sufficient [6]. In particular, problems exist related to lack of compe-
tence in wound management among home care nurses and GPs, the
GPs  and municipalities’ roles in treatment and follow −up care are
unclear, and capacity problems exist in the specialist health service
as  well as varying and unclear referral practices between primary
http://dx.doi.org/10.1016/j.ijmedinf.2016.06.020
1386-5056/© 2016 Published by Elsevier Ireland Ltd.
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Table 1
Characteristics of the participants.
Telemedicine
follow- up N = 13
Traditional
follow-up N = 11
Sex





50–59 3  –
60–69 4  3
70–79 2 4
>80 3 –
Mean (r) 62.6 (47–88) 60.4 (38–76)
Type of diabetes
Type  1 2  4






Work full-time/Part-time 5 4
Retried 7 3
Sick leave 1 –
Disabled – 4
Co-morbidities – –
Coronary disease 3 3




Geographical distance from settlement to hospital, km. median (r) 11.4 (0.5–72.6) 10.7 (2.6–30.6)
− and specialist health care service [7–9]. A particular challenge is
related to lack of good communication technology between the two
levels.  Lack of collaboration between levels, with the consequence
that the patient does not receive timely treatment can lead to severe
consequences for the patients [8]. Diabetic foot ulcers are one of the
leading causes of hospital admission for people with diabetes and
the  most common cause of lower limb amputation [9,10].
Telemedicine is suggested to be one solution used to facilitate
the creation of a more integrated healthcare service, with the aim of
increasing access, quality, patient satisfaction, and treatment effi-
ciency in patients with diabetic foot ulcers [4,11,12]. Telemedicine
has been available in different healthcare disciplines and for var-
ious disease groups for decades. In wound care, much literature
exists on imaging technology and feasibility of the technology.
However, studies that have focused specially on diabetic foot ulcer
and  telemedicine are scarce. A systematic review from 2014 [13]
assessing the effect of telemedicine compared to traditional care
among patients with leg and foot ulcer concluded that the evidence
is inconclusive due to lack of studies and poor methodological qual-
ity  of the studies. The authors concluded that RCT studies with
larger samples and longer follow-up time are needed. In Denmark,
a recently published RCT [14] study including 401 patients with
diabetic foot ulcers found no difference in terms of wound heal-
ing or amputation. However, they found a higher mortality rate
among patients receiving telemedicine follow-up versus traditional
care. Based on that, the authors question the role of telemedicine in
monitoring diabetic foot ulcers, especially to subgroups of patients
that may  have poorer outcomes with telemedicine monitoring.
In contrast, a large RCT study in UK [15] including 3230 patients
with diabetes, chronic obstructive pulmonary disease or hearth
failure found that telehealth was associated with lower mortal-
ity. The latter study did not include patients with diabetic foot
ulcer. Hence, more studies are needed to evaluate the effects of
telemedicine follow up compared to traditional care as well as
how the incorporation of telemedicine impacts on the experiences
of  patients receiving such care. Also, few studies have explored
patients’ experiences with treatment for diabetic foot ulcers and
their satisfaction with telemedicine [4,16]. The few existing reviews
of  implementation of this technology examined patients’ satisfac-
tion with telemedicine and included various patient groups, but
not  patients with diabetic foot ulcers [17–19]. These reviews con-
cluded that the majority of studies varied in quality and had many
methodological problems.
There  is a need to supplement previous research by explor-
ing the patients’ perspective on wound management as patients’
experiences are an important contributor to improve the quality of
health  care services. In-depth knowledge of patients’ experiences
can help evaluate whether use of telemedicine is an appropriate
way to improve the service. In the present study, we employed a
qualitative approach, and patients included were part of a larger
ongoing cluster randomized controlled trial (RCT) (Clin.Trial.gov:
NCT01710774). This trial is investigating whether telemedicine
follow-up care for patients with diabetic foot ulcers who receive
home care in collaboration with specialist healthcare is an equiv-
alent alternative to traditional outpatient clinical follow-up in a
specialist healthcare setting. The main trial outcome for the larger
RCT is healing time.
The  telemedicine intervention consists of an interactive wound
platform, which uses a web-based ulcer record combined with a
mobile phone that allows counseling and communication among
nurses in community and specialist healthcare. Use of wound
images in combination with written assessments of the wound
might replace or supplement existing treatment follow-up. Both
groups receive treatment in primary and specialist healthcare,
and the purpose of patients receiving telemedicine follow-up is
to  reduce the number of consultations in the outpatient clinic in
the  specialist health care. More responsibility can then be trans-
ferred to primary healthcare that is in line with national guidelines
[6,20]. By obtaining knowledge of patients’ experiences receiving
telemedicine and comparing and contrasting these experiences
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Table 2
Main  topics covered by the interview guide.
Intervention group
1. The patient’s experiences with the foot ulcer and what he did when he discovered the ulcer
2. The patient’s experiences with receiving telemedicine treatment and follow-up from the home care nurse
3. The patient’s experiences with being followed up in specialist healthcare
4.  The patient’s’ experiences of being involved in wound management and decisions that concerned his treatment
5. The patient’s experiences with healthcare professionals’ use of the telemedicine equipment and healthcare professionals’ own views on using
images in wound care
6.  Whether the patient observed telemedicine collaboration between the home care nurse and specialist healthcare service during follow-up
7. The patient’s perception of whether he takes more responsibility for his own  health
8. The patient’s perception of what is the most important task home care nurses and experts at the outpatient clinic have in treatment and care
of patients with diabetic foot ulcers
Control group
1. The patient’s experiences with the foot ulcer and what he did when he discovered the ulcer
2. The patient’s experiences with receiving traditional treatment and follow-up from the home care nurse
3. The patient’s experiences with being followed up in specialist healthcare
4.  The patient’s experiences of being involved in wound management and decisions that concerned his treatment
5. Whether the patient observed any collaboration between the home care nurse or GP and specialist healthcare services during follow-up
6. The patient’s perception of whether he takes more responsibility for his own  health
7. The patient’s perception of what is the most important task home care nurses and experts at the outpatient clinic have in treatment and care
of patients with diabetic foot ulcers
with those of patients in the control group, we may  get new insight
into how this technology influences patients’ perspectives. Includ-
ing patients’ perspectives may  cultivate a more holistic view and
more tailored treatment. The aim of our study was therefore to
explore the experiences of adults with diabetic foot ulcers receiving
telemedicine compared to patients receiving traditional follow-up
healthcare delivered in the context of a clustered RCT.
2.  Methods
2.1. Study design
Interpretive description (ID), as described by Thorne [21], was
used as a strategy in the present study. ID is an inductive analysis
approach that addresses clinical research questions in a way that
can  inform and potentially change practice [21].
2.2.  Patients
Twenty-four patients (13 in the intervention group, 11 in the
control group), aged 38–88 years, were purposively recruited from
the  telemedicine RCT trial so that we could obtain a diverse study
sample in terms of group (intervention vs. control), age, gender,
employment, marital status, settlement, and comorbid conditions
(Table 1). Patients in this study were included if their foot ulcers
had healed, or at the end of intervention that last maximum for
12  months. The study nurse organized patient recruitment at two
clinical sites in Western Norway that are responsible for the larger,
ongoing cluster RCT study. The first author (HSS) contacted patients
who earlier consented to participate in an interview in order to
make an appointment for the present study. One patient declined
participation, citing current unfavorable health conditions. At the
time  of the interview, patients’ foot ulcers had healed completely
for most of the patients, except for three patients in the intervention
group and four in the control group.
2.3. Follow-up of intervention group and control group in the RCT
study
Patients in the telemedicine group were followed primarily by
home care service. However, every six weeks they visited the out-
patient clinic, where their foot ulcer was monitored. At a minimum
of once per week, the home care nurse would take a digital image
of  the patients’ ulcers and would send it to the expert wound care
team at the outpatient clinic for assessment and feedback. Assess-
ment of the wound image, together with a written assessment,
determined whether a patient would require more frequent con-
sultations at the outpatient clinic.
Patients in the control group underwent wound control every
2–4 weeks at the outpatient clinic, with follow-up by the home care
service between consultations. However, this did not take place in
combination with telemedicine follow-up. For some patients home
care  follow up was not needed.
Patients in both groups were included in the trial until their foot
ulcer healed, but for maximum of 12 months.
2.4. Data collection
All  interviews were conducted between March 2014 and May
2015, either in the patients’ homes or at their workplace. Each
interview lasted between 35 and 55 min.
A  semi-structured interview guide was developed, based on the
aim  of the study, our current contextual understanding of the treat-
ment, and care pathways for patients with a diabetic foot ulcer. The
interview guide was  piloted with one patient from each group of the
trial  to assess its usefulness. The guide was perceived as a functional
tool, and only minor changes were made.
The interview guide contained eight overall topics with sub-
themes for the intervention group and seven overall topics with
subthemes for the control group (Table 2). The topics were similar
for both groups, except for questions related to the patients’ experi-
ences with health professionals’ use of the telemedicine equipment
and users’ own views on using digital images and remote assess-
ment in wound care.
2.5.  Analysis
Interviews were transcribed verbatim. The analysis process
comprised four phases: [1] researcher immersion in the transcripts,
[2] coding and developing of themes, [3] comparing and contrast-
ing themes within the groups, and [4] comparing and contrasting
themes between the groups (telemedicine vs. control). By follow
these phases, it was  possible to obtain comprehensive insight into
the  data, which in turn afforded us the opportunity to examine
the similarities and differences that emerged from the data. Each
author analyzed the data individually, and then all authors con-
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vened to discuss the data. This was done to ensure credibility and
obtain consensus at the interpretation of the individual themes that
emerged during the four-phase analysis process.
Immersion in the transcripts began immediately after each
interview, in which field notes were prepared containing obser-
vations of the setting and overall impressions from each interview.
The first author then transcribed all interviews directly after com-
pletion of each interview. Each transcript ended with preliminary
interpretations of the text, which were used for further analysis.
This enabled us to get an overall impression of the data. The tran-
scripts were then read in their entirety in order to get a sense of the
whole.
In  the second phase, we used open coding. Here, we chose codes
to match closely to the language inherent to the data. The different
codes were then sorted into groups of data that seemed to be the-
matically related. In this process, different tentative themes were
identified; these were used as a basis for further analysis.
We  used a constant comparison method [21] to compare the dif-
ferent parts of and patterns in each interview and to compare the
intervention and control groups. In phase three, first we  performed
a “within-group comparison” by assessing the telemedicine inter-
vention patients for similarities and differences. The same was  done
with  the data from the patients in the control group. Then, we per-
formed a “between-group” analysis by comparing themes from the
intervention and controls groups. Both positive and negative pat-
terns emerged from both group analyses. Further analysis revealed
remarkable similarities between the two groups (intervention vs.
control) and between members within each group. By comparing
and contrasting these positive and negative patterns within and
between groups, it was possible to conduct a more holistic analy-
sis. This in turn enabled us to identify the final themes within the
overall dataset common to both groups.
In the final phase of analysis, we identified three themes; com-
petence of healthcare professionals, continuity of care, and easy
access to healthcare services, that appeared to play an essential
role in patients treatment and follow-up care.
2.6.  Ethical considerations
The  study was approved by the Western Norway Regional Com-
mittee for Medical and Health Research Ethics (2011/1609/REK
vest). All participants received written and oral information about
the  study. Participation was voluntary, and each patient signed an
informed consent form.
3.  Results
The most important requirement expressed by adults with dia-
betic foot ulcers was to feel secure about or have confidence in
their ulcer treatment and follow-up. Fear of amputation or new
wounds were fundamental for the patients in both groups. Conse-
quently, experiences of security and confidence were fundamental
premises for how they experienced the treatment and follow-up
care. Some felt confident they were receiving care that would
benefit wound healing. Others felt doubtful that the care they
were receiving would promote wound healing. The type of ser-
vice (telemedicine vs. traditional) seemed less important in terms
of  how the patients experienced follow-up care. They emphasized
competence of healthcare professionals, continuity of care, and easy
access to healthcare services as the most important elements that
helped them gain security and confidence about the wound care
they were receiving. Both competence of healthcare profession-
als and continuity of care were seen as essential for providing
high-quality foot ulcer care. The presence of both elements would
contribute to improve the quality in handling of the foot ulcer,
whereas  their absence would not. The analysis also revealed pos-
itive process with telemedicine follow-up care. For instance, with
the  patients in the telemedicine intervention, taking an image with
the  mobile phone could quickly capture changes in healing. In a
matter of minutes, the home care nurse can take mobile phone
images of an ulcer and forward them to the expert team at the
outpatient clinic, allowing both of them to evaluate the ulcer and
discuss what treatment course to take. Although easy access to
wound care was generally important for all the patients, the impor-
tance of accessibility appears first when competence of healthcare
professionals and continuity of care were present.
3.1.  Competence of healthcare professionals
With respect to competence of nurses, patients stated that
knowledge of ulcer management and ability to teach patients about
proper ulcer care were important contributors to the quality of
care and patients’ sense of security. These sentiments were true for
both  telemedicine patients and control patients. Meeting nurses
and other health professionals who had specialized skills in ulcer
treatment, gave them a sense of security that they were receiving
high-quality foot ulcer care and that severe complication could be
avoided such as osteomyelitis and amputation. Patients viewed fre-
quent  assessments by a doctor important only if their wound was
not  healing as expected.
The  patients viewed home care nurses and nurses at the outpa-
tient clinic differently. At the outpatient clinics, all patients (both
intervention and control) were assessed by expert wound care spe-
cialists. Regarding these meetings, all but two patients described
themselves as being “in secure hands” due to available expertise
and rapid referral, if needed, which was not possible in home care
settings. Most patients commonly stated: “They [specialists] know
how  to treat ulcers.” However, several patients also stated that it
was  important for them to learn about proper wound care from the
nurse  wound specialists at the outpatient clinic. This gave them a
feeling of being empowered, because acquiring appropriate wound
care  knowledge would help them prevent their ulcer from worsen-
ing, prevent recurrence of the ulcer, and prevent new ulcers from
forming. As one patient said:
“If  they only treat the ulcer but do not facilitate learning, there is a
risk  that the patients will come back with a new ulcer” (IG19).
Contrasting with their experience at the specialist clinics, the
patients stated that they encountered large differences in knowl-
edge and experience among home care nurses. This situation made
them feel either secure or insecure, depending on the nurse’s exper-
tise  in wound care. Patients who received care from home care
nurses having extensive ulcer management experience described
them as possessing a strong commitment and interest in the ulcer
healing process. They viewed these nurses as highly skilled, compe-
tent in foot ulcer care, and qualified to treat their ulcers. Often, they
used descriptions like, “engaged,” “enthusiastic,” “[having] great
interest in wounds.”
On  the other hand, patients treated by home care nurses who
clearly lacked competence in wound management had a very differ-
ent  perception of their nurses. Not surprisingly, nurses who lacked
skills and a professional attitude made patients feel uneasy with
their treatment. Patients were afraid that these nurses overlooked
important signs of ulcer deterioration. Both control patients and
telemedicine patients expressed the same concerns. This sentiment
was conveyed by one man  in his 70s as follows:
“I  do not trust the home care nurses. They are so uncertain. They
ask  me what to do! I say that I cannot decide that. I  feel that I am
more  of a [wound care] specialist than they are. If changes occur in
the ulcer, I have the impression they do not know this is happening,
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because they have not seen the ulcer for 14 days. They have no
information  about the ulcer treatment process; they do not know
what  has been done with it. None of the home care nurses who have
treated  the ulcer have competence in ulcer treatment” (CG 2).
Another patient stated:
“I had to explain to the home care nurses how they should treat my
foot  ulcer, because they treated the ulcer very differently. I knew
more  about wound care than the nurses” (IG9).
These  representative quotes show how lack of competence in
home care service affected whether the patients felt secure with
the  care they were receiving.
3.2.  Continuity of care
3.2.1.  Receiving ulcer treatment from fewer nurses made patients
feel  more secure
The  patients described various experiences when several nurses
were involved in performing the follow-up ulcer management care.
Regardless of treatment group (telemedicine or control), the num-
ber  of nurse caregivers influenced whether the patients felt secure
with the ulcer care they were receiving. In general, they pre-
ferred care from fewer nurses, because they felt that, with fewer
caregivers, the nurses would be more familiar with their particular
ulcer, would be more up-to-date on the ulcer healing process and
treatment procedure, would be more knowledgeable about ulcer
treatments, and would have better communication with the outpa-
tient clinic. If this was not possible, patients felt it was important to
have  only one nurse oversee treatment, so that responsibility over
the  treatment was not distributed among several nurses. Patients
said this arrangement worked well and promoted good communi-
cation among the nurses. Being certain that nurses communicated
among themselves about the ulcer progress and treatment was
very important and was  emphasized as necessary in order for the
patients to feel secure with the ulcer treatment in primary health-
care. As one 60-year-old man  expressed it:
It was fantastic to be followed up by two nurses. They were up-
to-date  on the ulcer, they were competent, and both had read and
followed  the procedures that were sent from the outpatient clinic.
They  had a very positive commitment to wound management. For
me,  it was very stimulating and very reassuring (CG7).
One man  in the intervention group described follow-up care by
home care nurses like this:
“It  was  one nurse who had primary responsibility for ulcer treat-
ment  and follow-up and communicating with the outpatient clinic.
She  was available when she was needed, both for me and the other
nurses.  It was a brilliant way to do it” (IG5).
Patients  followed up by many different home care nurses did not
experience such a positive experience. In their case, no one person
oversaw their ulcer treatment. Moreover, the nurses involved were
not  up-to-date on the ulcer’s progress. One patient with a compli-
cated, slow-healing ulcer described his experience with home care
nurses in the following way:
“What was so sad is that a new nurse came almost every time, and
when  I asked them how the ulcer looked like, they would say that
they  had no idea. They had not seen the ulcer for one to 1.5 months.
Few  images were taken. I feel not very secure when they cannot tell
me  how the ulcer is healing” (IG 12).
3.2.2.  Telemedicine can benefit patients
The patients in the two groups (telemedicine vs. control) had
very similar experiences. It seemed, however, that care deliv-
ered  via telemedicine could counteract some of the challenges
the patients experienced during the treatment process. Still, this
depended on whether telemedicine was  carried out as intended.
Telemedicine  patients who had positive experiences with
their telemedicine care stated that images of the ulcer com-
bined with a written assessment contributed positively to ulcer
treatment, because the images reinforced the written assess-
ment of the foot ulcer. Several of the telemedicine patients
used the adage, “one image speaks more than a thousand words,”
to describe their positive experience. The patients stated that
the telemedicine protocol worked well, because it gave them
the assurance that if something was  wrong with their ulcer,
it would be quickly caught by the outpatient clinic expert
team, who assessed the images. This sense of confidence in
the treatment scheme was expressed by one man  as fol-
lows:
“The  digital communication between the outpatient clinic and the
home  care nurse, and image transfer gave [me a feeling of] security
that,  if there was some changes in the ulcer healing, the health
professionals  at the outpatient clinic would catch it” (IG19).
Patients also noted that taking wound images was a good tool,
because it helped the home care nurses be more observant and
improved their wound care knowledge and skills. This notion is
exemplified in the following quotation:
“[The  fact] that the home care nurses take images of the ulcer has
made  them very observant. They do what they should [do]” (IG5).
The patients also observed that the act of taking and sending
images of the ulcers to and having them assessed by the outpatient
clinic also gave the home care nurses a sense of security. One 62-
year-old man  expressed this in the following way:
“It was reassuring for the home care nurses to communicate with
the  expert team at the outpatient clinic, because they received feed-
back  on whether they were on the right path or not” (IG20).
The communication between the home care nurses and out-
patient clinic also improved, because the assessed image and
treatment procedure were sent directly to the home care nurses
through the shared web-based ulcer record used both by experts
in the outpatient clinic and home care nurses. That allowed direct
communication between the two  levels. In the control group, how-
ever, the treatment procedure was  given to the patient.
The  use of images in telemedicine also increased the sense
of security of patients who received follow-up care from many
nurses with varying expertise. One woman expressed this sense
of  enhanced security in the following way:
“There  were many nurses involved [in my wound care] who lacked
wound  skills compared to [those at] the outpatient clinics. It there-
fore  was of great comfort for me that images [of my ulcer] were
taken  and sent to the outpatient clinic for assessment” (IG 4).
These examples show that telemedicine can support a treatment
intervention in a positive way. However, if telemedicine was not
carried out as planned—for example, images were not taken or not
sent, or outpatient clinic did not assess the images—telemedicine
did not benefit the patients. Some of the telemedicine patients men-
tioned that some home care nurses did not take images of their
ulcers due to lack of mobile skills, during sick leave and vacation.
Others reported that the outpatient clinic did not respond to the
home care nurses’ request to assess the images. One man  in his 50s
observed the following:
“The home care [nurses] did not take any images of the foot ulcer.
They  did not start [taking] images before the wound was healed
(IG17).
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3.3. Easy access and close proximity to home care service
Easy  access and proximity to the service appeared to be impor-
tant for the patients. For some patients, this was an excellent care
pathway; for others, easy access and proximity were less rele-
vant. These perceptions were independent of whether the patients
received telemedicine care or not. If home care service was avail-
able and of sufficient quality, patients preferred to receive ulcer
treatment and follow-up from a home care nurse rather receive
frequent control at the outpatient clinic. As two patients put it:
“If  the home care nurses have the necessary expertise and commu-
nicate  well with the outpatient clinic via the images, I see no reason
to  travel often to the outpatient clinic” (IG20).
“There are two home care nurses who had the responsible for the
ulcer  treatment, one each time. I experienced them as being com-
petent  and professional. And it is sufficient to have two  follow-up
checks  per month at the outpatient clinic” (CG16).
Employed  participants and sick patients emphasized that
receiving treatment close to home afforded flexibility in choosing
both the time and place of treatment, which reduced traveling time
to  and waiting time at the outpatient clinic. For employed patients,
this allowed them to go to work during wound healing.
On  the other hand, if the home care service lacked compe-
tence and continuity, the patients decided to decline the home
care service and instead receive all treatment and follow-up at the
outpatient clinic. Two patients commented:
“I  would rather use the car and drive to the clinic instead of getting
treatment  from the home care nurses, because the follow-up by the
home care nurse made me  unsecure ” (IG 9).
“I  have declined home care [because] many nurses lacked compe-
tence.  I was  followed up at the outpatient clinic, but I did the wound
care  myself between the consultations” (CG15).
These patients stated that travel time to and waiting time at
the outpatient clinic were less important. This may  indicate that
easy access and proximity were less significant factors than com-
petence and continuity, because the latter contributed most to a
feeling of security, a factor that was strongly emphasized by the
patients. Some patients also requested more frequent checks at the
outpatient clinic, but said that this option was not possible because
of  capacity problems at the outpatient clinics.
4. Discussion
The aim of this qualitative study was to explore the experiences
of adults with diabetic foot ulcers receiving telemedicine compared
to patients receiving traditional follow up in the context of a clus-
tered RCT study. The discussion will be structured around the main
themes identified.
4.1.  Competence of the health care professionals
This study has shown very clearly that competence in wound
management of health professional was of great importance for
patients’ experience of security during wound care. Nurses’ com-
petence at the outpatient clinic emerged as very essential to the
patients, because expert knowledge and skills in wound care made
the  patients confident that if changes in the wound occurred this
would be detected and necessary action taken. Patients also stated
that  effective teaching of patients about wound care occurred
mainly at the outpatient clinic by specialist nurses and was less
frequently done at home by home care nurses. This perception is
in  line with other studies that concluded that specialists in wound
treatment  have a key role in empowering patients in self-wound
care [22].
The  level of acquired wound-care knowledge and skills varied
among the home care nurses, according to the patients. This percep-
tion corroborates findings from other studies [3–5]. Independent of
group  affiliation (both in intervention and control group), patients
who were treated by home care nurses lacking competence felt
insecure about their wound management. An important issue
was that these patients wanted to receive all their treatment at
the  outpatient clinic, but this was  not feasible due to capacity
problems. Nevertheless, for these patients, the outpatient clinic
turned out to be an important confidence factor for them, because
they received confirmation of whether their wound management
received through home care was adequate. Education of home care
nurses to ensure appropriated treatment practice is of importance
and one of the cornerstones in foot management [23]. The home
care nurses interact with people at high risk of severe complications
and lack of awareness with regard to treatment and follow-up care
practice can lead to unnecessary poor outcomes and hospitaliza-
tions [24]. In our study, the patients reported that learning mainly
occurred at the outpatient clinic. Thus, improved knowledge among
the  home care nurses can indirectly empower patients through
teaching them about how to recognize foot problems, promote
appropriate self-care, and thus contribute equivalent to the expert
team in patient education. That can change the current perception
among the patients and prevent foot ulcer in people with diabetes
[24]. However, a cautious approach of telemedicine monitoring in
patients with severe foot ulcer diseases should be considered [14],
especially if lack of wound knowledge and training in telemedicine
equipment are shortcomings among the staff involved.
When  few nurses in home care service were responsible
for the wound care, patients’ sense of security and confidence
increased, and this seemed to be an important issue in wound
management for patients. Correctly implementing telemedicine
seems to further contribute to this increase. Most patients receiv-
ing telemedicine felt that it was  a useful adjunct to the other
treatment they received. This apparently enhanced their feel-
ings of security, resulting in assurance that the expert team at
the outpatient clinics and home care nurses used mobile phone
images appropriately. Patients reported that this enhanced wound-
management competence among the home care nurses. Current
evidence shows that using telemedicine in combination with
communication with other healthcare professionals, enhanced
competence in wound management among the home care nurses
[4,5,25,26]. Using telemedicine, the home care nurses collab-
orated closely with the nurses at the outpatient clinics. The
collaboration involved continual feedback on performed work
via discussions and reports from nurses at the outpatient clin-
ics that seem to strengthened patient confidence. This finding is
in  line with other studies [4,5,27]. Similar collaboration in tradi-
tional follow-up in which there is no formal cooperation among
levels of care was  not experienced in the same way by the
patients.
We observed in our settings that use of telemedicine could be
questionable in a number of circumstances. Some of the patients
receiving telemedicine reported that the nurses failed to take
any mobile phone images, and some nurses lacked the necessary
mobile-device skills. Similar issues have been reported in other
studies [26,28]. If telemedicine is to have any benefit for the patients
and operate successfully, these barriers must be removed. Several
studies have emphasized that innovative technologies need to be
integrated in the stakeholders’ routine practice. The technologies
must be easy and as fast as possible to use, with necessary initial
training and continuously support. If not, there is a major risk of
failure [25,26,29].
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4.2. Continuity of care
Our  analyses also showed that continuity of care in wound man-
agement is another confidence-building factor that is essential to
patients. Freeman and colleagues [30] described three dimensions
of continuity of care: interpersonal continuity, informational con-
tinuity, and management continuity. The interpersonal dimension
refers to the ongoing therapeutic relationship between providers
and patients. The information dimension refers to the links of
information between episodes of care and transitions, and com-
munication between provider and patient. These two dimensions
are identifiable in our data.
Patients  in both groups reported that they preferred being
followed up by a limited number of home care nurses. This is con-
sistent with the findings of other studies [31–33]. Indeed, receiving
care from just a few home care nurses increases patient well-being
and security [31]. Constancy of a small number of home care nurses
can  increase their chances of detecting subtle changes in the ulcer-
healing process, thereby avoiding severe complications such as
osteomyelitis and amputation. This was a major concern for the
patients in this study.
Although  continuity of care in primary healthcare has a posi-
tive effect on outcomes [32], it can be difficult to implement due
to  variable shift schedules, and contextual and individual factors
[31,33]. The patients of our study were familiar with those issues.
Telemedicine can reduce the uncertainty or anxiety that these types
of  issues can create, because telemedicine can promote continu-
ity of care via efficient information exchange, regardless of which
home care nurse follows up the patient. So, any uncertainty a
patient may  experience can be remedied by the fact that home care
nurses have quick access to wound care specialists, who analyze
the ulcer images and prepare a written assessment of the ulcer.
This enables the nurses to appropriately treat the ulcer in a timely
fashion. Patients receiving traditional care did not report similar
experiences. This is consistent with other studies that show that
telemedicine can increase exchange of knowledge and informa-
tion between healthcare professionals, between levels of care, and
between patients and healthcare professionals [34].
However,  continuity of care cannot be viewed as being inde-
pendent of caregiver skill and knowledge of wound management.
Woodward and colleagues [35] found that consistently applied
knowledge and skills of several healthcare professionals and con-
sistent care management were important for ensuring continuity
of care in home care settings. This was the case in our study as well.
Taken together, consistent service and care delivery by knowledge-
able and skilled home care nurses were factors that fostered the
patients’ confidence that they were receiving quality care.
4.3.  Easy access
Easy  access was an important factor in wound treatment, but
it  depended on whether competence and continuity of care were
established. This outcome was regardless of whether the patient
received telemedicine or not. When both factors were presented,
follow-up in the primary health care was an excellent care path-
way. Thus, it is not necessary to charge the specialist health service
with a service that can be done equally well in the primary health
care. This is in line with the lowest effective service level (LEON)
principle that the services should take place in close connection
to the home environment [20]. Telemedicine seem to be an addi-
tional factor that may  contribute to increase patient satisfaction
at LEON level. This will reduce the number of consultations at the
outpatient clinic. In this way, resources can be better channeled to
patients who need more frequent follow-up by the expert team in
specialist healthcare.
Follow-up by the home care nurses gave a flexibility in the
wound care that did not happen to the same degree at the out-
patient clinic. This flexibility was an important factor for patients
who were employed, because they wanted to use the least amount
of time on treatment and travel. Without this flexibility, patients
reported that they would not be able to go to work. However, for
patients who were uneasy with receiving home care follow-up,
traveling to and waiting at the outpatient clinic were of little impor-
tance. These patients are concerned about feeling safe and secure
and having confidence in their treatment. One solution could be to
allow  the patient to a greater extent be involved to determine ways
to  be treated. Being involved in their own care pathway and par-
ticipate in decisions regarding their own health can provide better
quality of wound care. This is emphasized in national guidelines
[20].
The use of individual face-to-face interviews with the patients
was effective in collecting relevant data. The possibility of using a
focus  group interview instead was  a relevant alternative that was
discussed, but was  not selected because patients lived in different
municipalities, often were older on average, had reduced mobility
and health, and often depended on help from relatives or healthcare
professionals to get from one place to another.
This study included a sample size of 24 patients purposely
selected from an ongoing RCT. We believe that this sample size
was large enough to sufficiently achieve the aim of the study.
The  patients participating in the trial were also a selected group
of patients based on inclusion criteria. Their experience might differ
from  more seriously ill patient populations, who were excluded
from participation in the trial.
5. Conclusions and implications for practice
Our study shows that an effective wound care pathway for
patients with diabetic foot ulcers depended on professionals’ com-
petence and professional skills in wound management and on
continuity of care. The interaction between the two factors not
only promotes more integrated care, but also bolsters patients’
confidence in their ulcer care. Telemedicine can be an important
supplement in that process, but its efficacy will depend on whether
telemedicine is used as intended. Education and practical training
in the use of telemedicine should be given to all health care pro-
fessionals in the primary health care and not simply to a few [25].
Also clear guidelines for delegation of responsibility in case of sick-
ness  and vacation among key staff must be clarified. The quality of
the  service can thus be strengthened and lack of documentation be
avoided.
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Summary points
What was already known?
• In the current system, the care pathway for patients with
diabetes foot ulcers is not optimal.
• Previous telemedicine research in wound care has primarily
focused on technology development and feasibility.
• Few studies have explored patients with foot ulcers experi-
ences with use of telemedicine.
What this study adds:
• The best wound care pathway for patients with diabetes foot
ulcers is depended on a combination of competence and
professional skills in wound management, and continuity of
care.
• Professional competence and skills in would management is
essential for a flexible health service enabling more patients
to be treated in home based care.
• Telemedicine seem to be an important supplement to cre-
ate a more integrated wound care pathway, but is depended
whether telemedicine is implemented as intended.
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1. Har pasienten blitt behandlet for fotsår før 01.01.2009? 
 Ja        Dato  
Nei  
 Hvis ja, antall ganger:  
 
2. Har pasienten blitt behandlet for nye fotsår i perioden 01.01.2009 -31.12.2011? 
 Ja    
Nei  
 Hvis ja, hvor mange:                   Type sår:  
 
3. Dato for første konsultasjon ifm fotsåret i perioden 01.01.2009 -31.12.2011? 
 Dato: 
 
4. Dato for siste konsultasjon ifm det første fotsåret i perioden 01.01.2009 -31.12.2011? 
 Dato:  
 
5. Alder ved første konsultasjon:  
 
6. Antall uker fra henvising til mottatt time i spesialisthelsetjenesten? 
 Uker: 
 
7.  Dato pasienten rapporterte å ha fått fotsåret?  før første konsultasjon 
 Dato/år:            eller  måned/år: 
 
8.  Dersom hjemmesykepleie - hvor lenge har pasienten vært behandlet i hjemmesykepleien før  
pasienten fikk time i spesialisthelsetjenesten for fotsåret sitt? 
 Uker:               eller  måneder:  
 
9.  Dersom fastlegen behandler fotsåret - hvor lenge har pasienten vært behandlet av fastlegen før  
pasienten fikk time i spesialisthelsetjenesten for fotsåret sitt? 
 Uker:                eller  måneder:  
 
10. Hvem henviste pasienten?   
 Fastlegen  
 Spesialist  















11. Antall innleggelser på sykehus relatert til første fotsår i perioden 01.01.09-31.12.11: 
 Dato:             Årsak:   
 Dato:             Årsak: 
 Dato:             Årsak: 
 
12. Totalt antall konsultasjoner på poliklinikken i forbindelse med første fotsår: 
 2009 Antall konsultasjoner: 
 2010 Antall konsultasjoner: 
 2011 Antall konsultasjoner: 
 
13. Geografisk avstand mellom bopel og poliklinikk 







14. Kjønn:  Mann      
  Kvinne   
 
15.  Fødselsår:  
 
16. Arbeidstilknytning:  
 Jobber fulltid/deltid  
 Ufør/under attføring  
 Pensjonist   
 Hjemmeværende (uten lønn)  
 Ukjent   
 
17. Sivil status: 
 Gift/samboer  
 Ugift   
 Enke/enkemann  
 Ukjent  
 
18. Røyking: 
 Røyker   
 Tidligere røyker  
 Aldri røykt  
 Ukjent  
 
19. Etnisitet: 
 Etnisk norsk   













DIABETES-RELATERTE KJENNETEGN  
 
20. Type diabetes:  
 Diabetes I  
 Diabetes II  
 
21. Debut år diabetes: 
 
22. Diabetesbehandling:  
 Insulin  
 Antidiabetikum.  
 Kostregulert  
 
23. Nærmeste HbA1c i forhold til første konsultasjon perioden 01.01.09-31.12.11: 
 Hba1c.                                      data/år: 
 
24. Makrovaskulær komplikasjon:  
  Cardiovaskulære sykdommer: 
ex hypertensjon, tidligere 
hjerteinfarkt, angina pectoris, 
hjertesvikt, TIA, slag, opr. for 
trange kar, claudicatio 
 spesifiser  
 
25. Mikrovaskulær komplikasjon:  
  retinopati, nefropati og 
neuropati 
 spesifiser  
 





FOTSÅR - RELATERTE KARAKTERISTIKA - Kliniske 
 
Klassifisering av fotsåret ved første konsultasjon i perioden 01.01.2009 – 
31.12.2011 
 
27. Klassifisering ved innkomst: 
 Ischemisk  
 Neuropatisk  
 Ischemisk/neuropatisk sår  
 
28. Sirkulasjonsutredning ved innkomst: 
 Ankel-arm index  Ja   Nei  Resultat: 
 Tå trykk måling Ja   Nei  Resultat: 
 Angiografi Ja   Nei  Resultat: 
 Puls a. dorsalis pedis Ja   Nei  Merknad: 
 Puls a. tibialis anterior Ja   Nei  Merknad:  
 







29. Nevrologisk undersøkelse ved innkomst: 
 10-g monofilament Ja   Nei  Resultat  
 
30. Infeksjon/osteomyelitt:  
 Infeksjon ved diagnose: Ja   Nei  
 Infeksjon underveis i behandlingen: Ja   Nei 
 Bakteriologisk u.s. tatt ved infeksjon: Ja   Nei 
 Administrering av antibiotika ved 
infeksjon? 
 Intravenøst 
 Per os  
Ja   Nei  
 
Ja   Nei antall dager: 
Ja   Nei antall dager: 
 Osteomyelitt ved diagnose: Ja   Nei  
 Osteomyelitt underveis i behandlingen: Ja   Nei 
 Administrering av antibiotika for 
osteomyelitt? 
 Intravenøst 
 Per os  
Ja   Nei 
 
Ja   Nei antall dager: 
Ja   Nei antall dager: 
 
31. Karkirurgi ved diagnose: Ja   Nei  spesifiser type:  
 Karkirurgi underveis i behandlingen: Ja   Nei  spesifiser type:  
 
32. Antall sår ved innkomst:  
 
33. Sårlokalisasjon ved diagnose: 
 Tå regionen  spesifiser:  
 Metatarsal område  spesifiser: 
 Midt fot/hindfot område  spesifiser: 
 Multiple områder  spesifiser: 
 Plantar  spesifiser: 
 Plantar metatarsal  spesifiser: 
 Hæl  spesifiser: 
 
34.  Sårets størrelse ved diagnose: 
 Lende:                   mm 
 Bredde:                 mm 
 Dybde:                  mm 
 
35.  Sårets utseende ved diagnose: 
 Nekrose   
 Infeksjon  
 Væskende  
 Ødem/hoven  
 Puss  
 Granulasjon   
 Rent   
 
36. Rapporter pasienten smerter?    Ja   Nei 
 Administrert 
smertestillende? 
Ja  Nei  
Hvis ja, medikament:               styrke/dose: 
 
 






37. UT classification ved diagnose 
  
Grade 0: 




















 Stage A: Rent sår     
 Stage B: PAD -   infeksjon +      
 Stage C: PAD +  infeksjon -     





SÅRBEHANDLING OG VIDERE OPPFØLGING I PERIODEN 01.01.2009 – 
31.12.2011 
 




Callus fjerning  
Spesifiser:  
Karkirurgi ved diagnose   Ja  Nei   Hvis ja, spesifiser: 
Karkirurgi underveis   Ja  Nei  Hvis ja, spesifiser: 
Offloading  Ja  Nei  Hvis ja, spesifiser: 
Infeksjonskontroll Ja  Nei   
Blodprøver Ja  Nei  
HbA1c, CRP, Lpk, albumin, kreatinin, 
ratio, HDL, GFR 
Hvis ja, spesifiser hvilke blodprøver og verdi: 
 
39. Hvilke profesjoner har vært involverte i behandling og oppfølging av pasienten? 
 Diabetes sykepleier       
Sykepleier                   
Endokrinolog                
Karkirurg 

















40. Såret grodd? Ja          Nei  Dato/år: 
 
41.  Amputasjon Ja          Nei  Dato/år: 
 
 






42. Pasienten døde før behandlingen var 
avsluttet? 
Ja        Nei  Dato/år: 
 
43. Har pasienten blitt fulgt opp av 
hjemmesykepleien i behandlingsperioden? 
Ja        Nei  Antall uker: 
 






Dersom pasienten har fått et nytt fotsår i perioden 01.01.09 – 31.12.11 
 






Main topics in the interview guide 
Intervention group  
1. The patient’s experiences with the foot ulcer and what he did when he discovered the ulcer 
2. The patient’s experiences with receiving telemedicine treatment and follow-up from the home 
care nurse 
3. The patient’s experiences with being followed up in specialist healthcare 
4. The patient’s’ experiences of being involved in wound management and decisions that 
concerned his treatment 
5. The patient’s experiences with healthcare professionals’ use of the telemedicine equipment 
and healthcare professionals’ own views on using images in wound care 
6. Whether the patient observed telemedicine collaboration between the home care nurse and 
specialist healthcare service during follow-up 
7. The patient's perception of whether he takes more responsibility for his own health 
8. The patient’s perception of what is the most important task home care nurses and experts at 
the outpatient clinic have in treatment and care of patients with diabetic foot ulcers 
 
Control group 
1. The patient’s experiences with the foot ulcer and what he did when he discovered the ulcer 
2. The patient’s experiences with receiving traditional treatment and follow-up from the home 
care nurse 
3. The patient’s experiences with being followed up in specialist healthcare 
4. The patient’s experiences of being involved in wound management and decisions that 
concerned his treatment 
5. Whether the patient observed any collaboration between the home care nurse or GP and 
specialist healthcare services during follow-up 
6. The patient's perception of whether he takes more responsibility for his own health 
7. The patient’s perception of what is the most important task home care nurses and experts at 
the outpatient clinic have in treatment and care of patients with diabetic foot ulcers 
 
 

